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Intracranial chemical injection (ICI) methods have been used to identify the locations
in the brain where feeding behavior can be controlled acutely. Scientists conducting
ICI studies often document their injection site locations, thereby leaving kernels of
valuable location data for others to use to further characterize feeding control circuits.
Unfortunately, this rich dataset has not yet been formally contextualized with other
published neuroanatomical data. In particular, axonal tracing studies have delineated
several neural circuits originating in the same areas where ICI injection feeding-control
sites have been documented, but it remains unclear whether these circuits participate in
feeding control. Comparing injection sites with other types of location data would require
careful anatomical registration between the datasets. Here, a conceptual framework is
presented for how such anatomical registration efforts can be performed. For example, by
using a simple atlas alignment tool, a hypothalamic locus sensitive to the orexigenic effects
of neuropeptide Y (NPY) can be aligned accurately with the locations of neurons labeled
by anterograde tracers or those known to express NPY receptors or feeding-related
peptides. This approach can also be applied to those intracranial “gene-directed” injection
(IGI) methods (e.g., site-specific recombinase methods, RNA expression or interference,
optogenetics, and pharmacosynthetics) that involve viral injections to targeted neuronal
populations. Spatial alignment efforts can be accelerated if location data from ICI/IGI
methods are mapped to stereotaxic brain atlases to allow powerful neuroinformatics tools
to overlay different types of data in the same reference space. Atlas-based mapping
will be critical for community-based sharing of location data for feeding control circuits,
and will accelerate our understanding of structure-function relationships in the brain for
mammalian models of obesity and metabolic disorders.
Keywords: injections, optogenetic, pharmacogenetic, pharmacosynthetic, mapping, stereotaxic, neuroinformatics,
DREADD
1. INTRODUCTION
In the past two decades, our abilities to acutely manipulate neu-
ral substrates controlling behavior in the living animal have
transformed substantially. New transgenic methods to control
brain circuits, such as in vivo site-specific recombinase technol-
ogy (Lakso et al., 1992; Orban et al., 1992; Gu et al., 1994),
viral-mediated expression or RNA interference (RNAi) (Davidson
et al., 1993; Chamberlin et al., 1998; Hommel et al., 2003),
optogenetics (Boyden et al., 2005; Lima and Miesenböck, 2005;
Bernstein et al., 2012) and pharmacosynthetics (Armbruster et al.,
2007; Farrell and Roth, 2013), are now being used to address how
complex, goal-directed behaviors occur from organized networks
of neurons. At present, only a few laboratories have used these
methods to study feeding behavior. These state-of-the-art meth-
ods are now rapidly finding their place in our scientific literature
alongside studies involving acute chemical microinjection meth-
ods to control behavior that were first developed over a century
ago, and first used for studying acute feeding control in 1954.
In this review, these methods will be examined in relation
to the neuroanatomical information they have provided to sci-
entists trying to identify brain regions and circuits controlling
feeding behavior. Section 2 includes a brief history of central
microinjection methods, focusing on injection sites and maps
of feeding control regions. I found the excellent handbook by
Myers (1974) to be an indispensible resource for most stud-
ies published between 1915 and 1972. In Section 3, I review
gene-directed studies used to study feeding behavior, including
site-specific recombinase technology, viral-mediated expression,
and RNAi, optogenetics, and pharmacosynthetics; highlighting
special experimental considerations related to these techniques
for documenting injection and probe sites, as well as populations
of neurons activated or transduced by viruses. In Section 4, a
framework is proposed for examining location data in the brain
in a manner that allows one to interrelate such data from mul-
tiple studies of the same brain region. I compare location data
obtained from chemical injection studies with those using newer
gene-directed methods. In Section 5, I argue that within studies
using intracranial injection methods, the careful documentation
of the locations of the injection sites or the cell populations
affected by such injections is critical for interrelating these loca-
tion data with data found in other types of studies. For exam-
ple, neuroanatomical tract-tracing studies have provided much
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information concerning the circuit connections of neurons in key
feeding control regions of the brain. Many of these regions have
also been targets of various intracranial central injection meth-
ods. Placing the injection sites found in one study in anatomical
registration with traced circuits documented in another can aid
in the formulation of plausible, constrained hypotheses concern-
ing how functional feeding circuits are controlled and organized.
The proposal is made, also in Section 5, that neuroinformatics
approaches provide a set of powerful tools to analyze diverse sets
of data that are linked by the location information they each
contain.
In this article, the focus is not on the circuits controlling food
intake (i.e., the biology), but rather how to contextualize neu-
roanatomical data with chemical and/or gene-directed microin-
jection data (i.e., methodology). Several cogent reviews cover
details about feeding (and related) control circuits (Stevenson,
1969; Myers, 1974; Swanson, 1987, 2000c; Loewy and Spyer,
1990; Blessing, 1997; Elmquist et al., 1999; Watts and Swanson,
2002; Llewellyn-Smith and Verberne, 2011). Since most chemical
injection studies concerning feeding control have been focused
on manipulations of rat hypothalamus, this structure is empha-
sized in this article, but a few key studies performed in other
brain regions [e.g., prefrontal cortex, nucleus accumbens, ventral
tegmental area (VTA), nucleus of the solitary tract] and in other
species (goat, rabbit, guinea pig, mouse) are also highlighted.
For newer methods involving viral injections, the reader will
find attention shifted more to the mouse, reflecting the greater
importance this animal model now has for scientists investigat-
ing feeding control. Before we discuss these topics, it is useful
to compare chemical injection studies with newer gene-directed
approaches used to control behavior.
1.1. INTRACRANIAL INJECTION METHODS TO ACUTELY CONTROL
BEHAVIOR
For our purposes here, the terms intracranial chemical injec-
tions (ICI) and intracranial gene-directed injections (IGI) will be
used to differentiate traditional, acute chemical injection meth-
ods (Myers, 1974) from recently developedmethods involving cell
type-specific insertion of engineered molecules, such as in vivo
site-specific recombinase technology (Lakso et al., 1992; Orban
et al., 1992; Gu et al., 1994), viral-mediated RNA expression
or interference (Davidson et al., 1993; Chamberlin et al., 1998;
Hommel et al., 2003), optogenetics (Boyden et al., 2005; Lima
and Miesenböck, 2005; Bernstein et al., 2012), and pharmacosyn-
thetics (Armbruster et al., 2007; Farrell and Roth, 2013). While
not fully inclusive of the possible combinatorial strategies that
can be employed to control engineered molecules in the brain,
the term IGI is being used deliberately to emphasize those vari-
ants of gene-directed methods that specifically involve injections
of various constructs into the brain. Also, in vivo microdialysis
and other related methods (push-pull perfusion, amperometry,
etc.) are not covered in this article, but the concepts discussed here
also apply to these methods.
Although ICI and IGI methods were developed nearly a cen-
tury apart from one another (Maxwell, 1906a,b; Hommel et al.,
2003; Balthasar et al., 2005; Adamantidis et al., 2007; Alexander
et al., 2009), both rely on the use of intracranial injections to
either deliver chemical ligands (ICI) or various genetically engi-
neered sequences (IGI), such as those encoding Cre recombinase,
short hairpin RNA (shRNA), neuropeptides, enzymes, ion chan-
nels, ion transporters, or receptors; deep within brain tissue to
control behavioral output. With ICI, the chemicals travel to their
targets either from crystalline or wax deposits slowly dissolv-
ing in the brain after implantation, or as pre-dissolved solutes
within inert “vehicle,” or carrier solutions; in rare instances, such
chemicals are also delivered by being secreted from tissue grafts
implanted at the site of interest (e.g., Flerkó and Szentágothai,
1957; see Myers, 1974). With IGI, the genetic sequences are pack-
aged within modified viruses that are injected into the brain
(e.g., Davidson et al., 1993), where the sequences are transduced
and expressed within neuronal populations, often in a promoter-
specific fashion (e.g., Zhang et al., 2010). Once expressed, these
molecules can be engaged in various ways that depend upon the
specific IGI approach used. For site-specific recombinase tech-
nology [(Sauer, 1987; Sauer and Henderson, 1988; Lakso et al.,
1992; Orban et al., 1992; Gu et al., 1994); reviewed in Sauer
(1998)], the viruses deliver a sequence encoding the enzyme,
Cre recombinase, to cells in a transgenic animal harboring LoxP
sequences genetically inserted to flank genes intended for dele-
tion, insertion, translocation, or inversion. For site-specific gene
deletion, the expressed Cre recombinase initiates splicing of the
sequence at LoxP sites within the specific cells where it has been
delivered by the virus. In viral-mediated RNAi, shRNA inhibits
the expression of particular molecules within the cell (Hommel
et al., 2003). In optogenetic methods, neurons can be activated or
inhibited via light pulses of specific wavelengths delivered from
implanted optical fibers situated in the vicinity of the expressed
light-sensitive ion channels (Boyden et al., 2005). In pharma-
cosynthetic methods (Armbruster et al., 2007; Farrell and Roth,
2013), activation or inhibition of “designer” receptors inserted
into cells by viral transduction occurs by “designer” ligands
injected centrally or that are delivered systemically and cross the
blood-brain barrier, such as the prototypical synthetic molecule,
clozapine-N-oxide (CNO).
Another similarity between ICI and IGI methods is that they
often involve combinations of intracranial manipulations. Thus,
prior to the injection of chemicals or viruses, these techniques
may first require the implantation of chronically indwelling guide
cannulas that facilitate rapid and reproducible insertion of the
injector needles or optical fibers into brain tissue. The first tissue
perturbation would therefore be from the cannula implantation,
and the second from the injector needle or fiber itself. In such
cases, the tissue is subjected to more than one invasive manipu-
lation. As discussed in the next section, the tissue itself supplies a
critical type of datum in ICI and IGI studies: location information
about the experimental manipulation.
1.2. SITES AND CELLS: THE ONLY VISUAL REFERENCES LEFT BY ICI
AND IGI ABOUT LOCATION
“. . . [N]etwork visualization is also the cartography of the indis-
cernible, depicting intangible structures that are invisible and unde-
tected by the human eye, from eccentric visualizations of the World
Wide Web to representations of the brain’s neural network. In some
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cases, the maps of these hidden structures are the only visual reference
we have, constituting its own alternative reality.”
—Manuel Lima (2011)
Visual Complexity: Mapping Patterns of Information
ICI and IGI studies of feeding behavior are conducted to achieve
certain goals. First, there is a need to understand the quali-
tative and quantitative aspects of feeding behavior itself, such
as feeding duration, latency to eat, timing and sizes of meals,
inter-meal interval durations, or responses to conditioned cues
(Brobeck, 1955; Le Magnen, 1985). Second, there is also a need
to localize the effects of intracranial manipulations to a set of
defined neural substrates. This is done by “identifying” brain
regions and the circuits within them that are responsible for
producing the behavior observed, based on probe locations in
the brain.
It is this process of “identification” that is the main concern of
this review. What can be identified within the tissue after using
ICI or IGI methods to mark the site of experimental stimulation
or suppression of feeding behavior? As will be detailed in Section
4.4.9.1. ICI and IGImethods leave several physical signs of experi-
mental perturbation: (1) tissue displacement from the delivery of
solutions carrying viral particles or dissolved chemicals; (2) tis-
sue damage from glass micropipettes, needles, or optical fibers;
(3) tissue damage from any indwelling cannulas used to guide
probes to target locations; (4) histochemically detectable reporter
molecules or tracers expressed or visualized in association with
experimental manipulation or viral transduction.
Echoing Lima’s statement above, the only visual references that
usually remain about the location of an ICI or IGI manipula-
tion, from which we can try and begin inferring the locations of
underlying feeding circuits, is what has been documented within
the published study for others to utilize. Importantly, it is useful
to consider this published documentation as the type of “alter-
native reality” Lima describes. By being consciously aware of
the rather underappreciated notion that the visual documenta-
tions of injection sites and cell location data—within a published
report—constitute a proxy for that which is unseen and inacces-
sible in the brain, we might be more attentive in making sure
that our published descriptions of such data, as a community,
are as informative as possible. In doing so, we are ensuring that
future scientists can fully access our datasets and bring them into
register with their own as yet uncollected data. I approach the
ingestive behavior community here with this argument, but it
also has been made elsewhere for functional human brain imag-
ing data (Devlin and Poldrack, 2007; Toga and Thompson, 2007;
Van Essen and Dierker, 2007). In Sections 4 and 5, we will see
how visual representations of data from the same brain region
can be interrelated across published studies. Before beginning this
topic, let us examine visual representations historically used to
document intracranial microinjections (ICImethods) controlling
feeding behavior.
2. THE EXPERIMENTAL CONTROL OF FOOD INTAKE USING
ICI: A BRIEF HISTORY
From the 1900s to the 1950s, various electrical stimulation or
lesioning methods were used to investigate the neural substrates
underlying feeding, autonomic and neuroendocrine control [e.g.,
the work of Karplus and Kreidl (Gehirn und Sympathicus, Parts
I–VIII: 1909, 1910, 1911, 1918, 1924, 1927, 1928; Einthoven
et al., 1927); the work of Hess in the 1920s and 1930s, reviewed
by Hess (1954, 1956, 1957), Camus and Roussy, 1920; Ranson
et al., 1935; Hetherington and Ranson, 1939, 1940; Anand and
Brobeck, 1951a,b; Delgado and Anand, 1953; reviewed by Ingram
(1939); Stevenson (1969)]. Moreover, studies of self-stimulation
since the 1950s [(Olds and Milner, 1954; Hoebel and Teitelbaum,
1962); reviewed by Olds (1977); Wise (2005); Berthoud and
Münzberg (2011)], linked feeding control to larger ideas about
drive and reinforcement. Alongside these methods, ICI meth-
ods also contributed richly to our understanding of how neural
substrates are causally linked to complex, goal-directed behav-
iors such as feeding. A few pioneering scientists first established
this causal link during the 1950s and 1960s, by acutely deliv-
ering chemical substances into the brain of the freely moving
animal to control feeding behavior (Larsson, 1954; Grossman,
1960; Epstein, 1960a,b). In this section, I trace the origins of
such chemical control and note a few key historical studies
that will be discussed within a larger theoretical framework in
Section 4 and 5.
2.1. NINETEENTH CENTURY ANTECEDENTS
The chemical control of brain function originated within the
larger intellectual discourse of the early to mid-nineteenth cen-
tury concerning the localization of nervous system function
(Fearing, 1930; Young, 1990). Table 1 shows some key develop-
ments during this time for chemical control studies of the brain.
Intracranial injections were ostensibly popularized by these devel-
opments, which laid the groundwork for a more careful exami-
nation of chemical agents upon central nervous system function.
By the early twentieth century, chemical studies became practical
laboratory textbook exercises (e.g., Jackson, 1917; Sherrington,
1919; Barbour, 1932).
2.2. A CENTURY OF INJECTION SITES
Figure 1 shows brain injection sites chronologically appearing
in selected scientific studies from the early 1900s to the present
day, beginning with Maxwell’s documentation of needle tracks
in the brain (1906a,b, Table 1), perhaps the first to be pub-
lished (Figure 1A). In the early twentieth century, several scien-
tists working in European laboratories were focused on ascer-
taining the locations of “centers” for the production of heat
(Wärmzentrum) and sleep (Schlafzone). For example, while trying
to study how calcium chloride injections might produce a febrile
response in cats, Demole (1927) found that the injections pro-
duced sleep and that potassium chloride injections triggered
arousal. Injections were marked using carmine or black dye
(Figure 1B).
Bengt Andersson in Sweden first demonstrated the intracra-
nial chemical control of a motivated behavior by showing that
drinking behavior could be elicited by sodium chloride injections
into the goat diencephalon (Andersson, 1952, 1953; Andersson
et al., 1958). In 1954, Andersson’s student, Stig Larsson, reported
that an intrahypothalamically injected sodium chloride solu-
tion also triggered feeding in sheep or goats. In the wake of
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Table 1 | Early studies investigating the chemical control of the brain.
Study Summary of findings
Flourens, 1832 Topically applied l’huile essentielle de térébenthine and teinture de Rousseau (turpentine oil and opium, respectively) on
rabbit cerebral lobes and observed that these two substances, applied to the same region of the brain, trigger different
behavioral outcomes, locomotion and torpor.
Sechenov, 1863 Demonstrated that chemically stimulating frog sciatic nerve with liquid or crystalline salt could affect excitability of the
medulla. See also Roitbak (1980).
Landois, 1887; Bickel, 1898 Applied powdered creatine, creatinine, urea derivatives, or other compounds to the surface of the cerebral hemispheres
and produced contralateral contortions of the body.
Roux and Borrel, 1898 Introduced a neutralizing tetanus antitoxin into two compartments of a tetanus-infected guinea pig: the peripheral
circulation and the brain. Building upon a study by Wassermann and Takaki (1898), who provided evidence that tetanus
toxin binds to nervous tissue, the scientists showed that introducing the antitoxin into the brain conferred immunity and
lowered mortality in the animals to a greater extent than peripheral administration of the antitoxin.
Chauffard and Quénu,
1898
On April 26, 1898, performed the first intracerebral injections of tetanus antitoxin via hypodermic needles on human
patients. See also Semple (1899). Similar treatments on human patients were made by a number of clinicians, but to
varying degrees of success. As Wilson (1997) describes, the practice was soon abandoned after it was reported that
intravenous or subcutaneous injections were actually superior means of antitoxin delivery.
Aronsohn and Sachs, 1885 Demonstrated that a needle puncture of the striatum could produce a temperature increase in the animal.
Meltzer, 1900 Among the first to perform intracerebral injections in animals, but did not document injection site locations. For related
comments, see Ehrlich (1899); Coriat (1905).
Donath, 1904 Among the first to perform intracerebral injections in animals, but did not document injection site locations.
Maxwell, 1906a,b Used glass capillary tubes to deliver creatine, sodium citrate and other solutions into the gray and white matter of
rabbits.
Barbour, 1912 Introduced an ingenious closed cannula system for routing cool water through the brain (but not into it) in order to alter
its temperature (which it did).
Hashimoto, 1915 Used an open guide cannula system for intracranial injection, perhaps for the first time, when blood serum was
delivered into the brain of rabbits to examine the ensuing febrile response.
Sahlgren, 1934 Demonstrated sleep-producing effects after intracranial injections of sodium phenobarbital (Luminalnatrium) in rabbits.
Masserman, 1937 Began reporting autonomic responses in cats following injections of various chemical substances into the brain, some
with known actions as neurotransmitters (Masserman, 1937, 1939a,b; Masserman and Haertig, 1938a,b; Masserman
and Jacobson, 1940; Masserman et al., 1940). Although these studies confirmed the hypothalamic control of autonomic
function reported during electrical stimulation (e.g., Karplus and Kreidl, 1909, 1910, 1911; Ranson et al., 1935; also see
Hess, 1954, 1956, 1957), they did not include documentation of the injection sites, and included only brief notes
concerning the nomenclature and stereotaxic atlas used (Clarke and Henderson, 1911), or in some instances (e.g.,
Masserman and Haertig, 1938a) the hypothalamic regions examined.
This is a list of selected studies investigating the chemical control of the brain in the nineteenth and early twentieth centuries.
these findings, two Yale University laboratories, directed by Neal
Miller and Paul MacLean, respectively, began exploring cen-
tral injection techniques (see Miller et al., 1955, 1956; Miller,
1956, 1957, 1965, 1992; MacLean, 1957a,b). In 1953, James Eglin,
Jr., a MacLean lab student, provided in his completed medical
school thesis what was perhaps the first anatomic documenta-
tion of injection sites producing autonomic responses by chemical
injection. Unfortunately, Eglin’s drawings (some reproduced for
the first time in Figure 1C) were never published. von Euler
and Holmgren (1956) took X-ray images of the implanted skull
(Figure 1D) to show cannula locations for their thyroxine injec-
tions into the anterior pituitary, which inhibited radiolabeled
iodine release from the thyroid gland. That same year, Fisher
reported that intrahypothalamic testosterone induced nest build-
ing and “maternal care” behaviors in male rats; conversely, co-
injected estrogen and progesterone induced heat in female rats
(Fisher, 1956 also see Fisher, 1964; Figure 1E). Also, intrahy-
pothalamically grafted ovary fragments (to introduce estrogen)
suppressed rat gonadotropin secretion (Flerkó and Szentágothai,
1957).
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FIGURE 1 | (A) This drawing is of a frontal section from a rabbit, first
published in 1906 by Samuel S. Maxwell at the University of California
(Maxwell, 1906b). It shows injection sites made into the cerebral cortex,
either at the superficial level of the upper gray (g) matter (needle track shown
by a), or more deeper into the white (w ) matter (needle track shown by b).
Injections of calcium oxalate were made to evoke movements in the animal;
these were only observed with injections into the white matter. Maxwell also
(Continued)
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FIGURE 1 | Continued
performed similar experiments on cats. (B) This drawing is Figure 1 of
Demole (1927), which provides a view of how injection sites were marked.
CaCl2 injections were made into the anterior hypothalamus of cats to
produce sleep. Note the needle track and its final termination, the injection
site, are marked by black dye that was included in the CaCl2 solution at the
time of injection. Formalin-fixed tissue was used so that the tissue was
relatively clear of blood, and gross anatomical landmarks were used within
the tissue to aid in documenting the location. (C) A portion of the hand
drawings included in the unpublished medical school thesis of Eglin (1953),
reproduced here with permission. Needle tracks are colored red in each
drawing. The colored dots have been added by the present author to denote
the observations Eglin recorded for each of the corresponding injections:
white circles: no effect; black: pupillary dilation; green: locomotion; yellow:
piloerection; red: growling; blue: licking; magenta: salivation. (D) X-ray image
of guide cannula and injector assembly within a rabbit test subject’s skull; the
acrylic holding the assembly has been drawn on the image as a white outline
(von Euler and Holmgren, 1956). (E) A diagram showing the representative
location of Fisher’s injection placements (1956) in the medial preoptic region
to trigger switching between sexual and maternal behaviors in male rats (the
diagram is from a review by Fisher published in 1964). (F) The
Nissl-counterstained photomicrograph included in Grossman’s report (1960)
of norepinephrine feeding following crystalline administration of
norepinephrine or carbachol into the perifornical hypothalamus. (G) The
Nissl-counterstained photograph showing needle tracks from the studies of
Epstein (1960b). (H) A modification of the Klüver–Barrera stain was used by
Leibowitz (1975) to stain the tissue from subjects given amphetamine
injections in to the lateral hypothalamus. This photo is from Figure 2C of her
study. (I) Representative injection site in the vicinity of the ventral tegmental
area, from Figure 4C of Cador et al. (1986), where enkephalin injection
stimulated food intake. (J) Injection site and accompanying map (from
Paxinos and Watson, 1986) where 10 nl of NPY was injected into the
perifornical hypothalamus to stimulate food intake (from Stanley et al.,
1993a,b,c). (K) Beta-galactosidase-stained needle track and injection site
marking extent of viral induction following injection of an adeno-associated
virus by Davidson et al. (1993) within an unstained brain. (L) Bilateral injection
sites where the GABAA receptor agonist, muscimol, was injected into the
lateral hypothalamus to attenuate feeding produced by subsequent injections
of glutamate receptor antagonists into the nucleus accumbens within the
same animal (Maldonado-Irizarry et al., 1995). (M) Injection site produced by
Scammell et al. (1996) within the preoptic region where prostaglandins
induce a febrile response; the injection site is marked by fluorescent beads
(enlarged by the present author in the inset to the right). (N) Injection site in
the perifornical hypothalamus where cyclic AMP analogs stimulate feeding
(Gillard et al., 1998). (O) Example of a vehicle-injected (top) and
DAMGO-injected (bottom) subject stained for Fos; Fos “plume” areas, as
measured by the authors, are indicated diagrammatically (from Peciña and
Berridge, 2005). (P) Fluorogold injection site and accompanying maps in
Swanson atlas space (Swanson, 1999) reported by Petrovich et al. (2005),
which retrogradely labeled neurons subsequently examined for activation
responses during cue-initiated feeding. (Q) Injection site characterization
within the ventral tegmental area by Hommel et al. (2006; from their
supplementary data) using immunocytochemistry staining patterns for
tyrosine hydroxylase (green panels) and the nuclear stain, DAPI (blue). (R)
Injection sites marked by immunostaining for the androgen receptor
following delivery of either vehicle (right side) or testosterone (left side); from
Williamson et al. (2010) (S) Photomicrographs reproduced from Lin et al.
(2011) in which a Nissl stain has been applied to a tissue section to help
localize an injection site made into the medial hypothalamus (S, top), along
with an adjacent tissue section stained for the peptide hypocretin/orexin (S,
bottom). (T) Location of the optical fiber used to drive Channelrhodopsin-2
(ChR2)-expressing AgRP neurons in the mouse arcuate hypothalamus and
stimulate feeding behavior. This fluorescence photomicrograph shows the
ChR2-expressing neurons in red, as visualized by the reporter molecule,
mCherry. The tissue has been counterstained blue using the nuclear label,
DAPI. From the supplementary data in Aponte et al. (2011). (U) Fos activation
(magenta) in POMC neurons (green) transduced with Channelrhodopsin-2
(tdtomato reporter expression; red) in the mouse ARH (from supplementary
data in Atasoy et al., 2012). Figures are reproduced with permission of their
original publishers, as noted here: Panel (D) (John Wiley & Sons, Ltd.); (E)
(Scientific American); (F) (The American Association for the Advancement of
Science); (G) (The American Physiological Society); (H,I and S) (Elsevier);
(J,L–P and R) (Society for Neuroscience); (K,T and U) (Nature Publishing
Group); and (Q) (Cell Press, Inc.).
In 1960, Sebastian Grossman, a Miller lab graduate student,
reported that feeding or drinking could be elicited in rats receiv-
ing intrahypothalamic crystalline deposits of norepinephrine
(NE) or carbachol, respectively. In parallel work, Alan N. Epstein
at the University of Pennsylvania reported similar findings,
albeit with procaine hydrochloride, hypertonic saline, and dex-
trose; substances without “neurotransmitter” actions (Epstein,
1960a,b). Both investigators photographed injection sites within
Nissl-stained tissue (Figures 1F,G). Although many have used
Nissl stains to help visualize injection site locations in brain tissue,
a few have combined these with other treatments. For example,
Leibowitz (1975) used a protocol (Wolf and Yen, 1968) modi-
fied from the original method of Klüver and Barrera (1953) to
visualize anterior lateral hypothalamic sites where amphetamine
suppresses feeding in rats, by labeling cells (using a Nissl stain)
and myelin sheaths (using Luxol Fast Blue) in the same tissue
(Figure 1H). Finally, extending work done by the Stanley labora-
tory establishing a role for glutamate and its receptor agonists in
feeding control through actions within the lateral hypothalamic
area (Stanley et al., 1993a,b,c, 1996; Khan et al., 1999, 2004; Duva
et al., 2001, 2002, 2005; Hettes et al., 2003, 2007, 2010; see Stanley
et al., 2011), Li et al. (2011) have carefully delineated the loca-
tions of feeding-sensitive sites for the glutamate receptor agonists
NMDA and AMPA by using rigorous methods for situating the
locations of their hypothalamic injections that triggered feeding
behavior (Figure 1S).
2.2.1. A note on peptides and feeding
The 1970s marked early efforts to deliver peptides, such as
insulin, directly into the hypothalamus (Debons et al., 1970;
Panksepp and Nance, 1972). Crystalline insulin deposited into
the ventromedial hypothalamus reduced food intake in nor-
mal and diabetic rats (Hatfield et al., 1974). In contrast, β-
endorphin stimulated feeding when injected into this region
(Grandison and Guidotti, 1977). Documenting peptide injec-
tion sites gained currency in the 1980s. Cador et al. (1986), for
example, found enkephalin injected into the VTA had a marked
effect on feeding (Figure 1I). Similarly, following reports that
intracerebroventricular neuropeptide Y (NPY) injection stim-
ulated food intake (Clark et al., 1984; Levine and Morley,
1984), Stanley and Leibowitz (1984) reported feeding produced
by NPY injected directly into the hypothalamic paraventricular
nucleus (also see Stanley et al., 1986), and that the periforni-
cal hypothalamus is the region most sensitive to NPY’s effects
on feeding (Stanley et al., 1993a,b,c) (Figure 1J). Several studies
have since reported feeding induced or suppressed by peptides,
including: bombesin, cholecystokinin, hypocretin/orexin (H/O),
Agouti-related peptide (AgRP), melanin-concentrating hormone,
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alpha-melanocyte stimulating hormone, and ghrelin (reviewed by
Kalra et al. (1999); Berthoud and Morrison (2008)].
2.3. A CENTURY OF MAPS
For ICI methods, issues concerning the spread of injected
solutions led to scientists usingmore sophisticated “cannula map-
ping” strategies to isolate the site(s) most sensitive to the auto-
nomic or behavioral effects of injected solutions. Any injection
site photographs included in these studies were now accompanied
by location data “mapped” to standardized brain atlases.
2.3.1. Early maps
Demole (1927) not only published some of the earliest pho-
tographs of brain injection sites (see Section 2.2), but also the
first detailed “map” of sites in the cat hypothalamus where injec-
tions produced sleep (Figure 2A). This work also included what is
possibly the first documentation of effective and ineffective injec-
tion sites in relation to gross anatomical landmarks on the ventral
surface of the brain. The two types of site were mapped to oppo-
site sides of the midline for diagrammatic purposes; stylistically,
this use of mirrored hemispheres finds currency in later injection
site maps (e.g., Stanley et al., 1993a,b,c). Comparing Figure 1A
with Figure 2A, it is clear that although Demole cut brains in the
coronal (transverse) plane, the “map” is in the horizontal plane.
Therefore, the clearly subjective transformation involved to map
the sites from one plane to another likely introduced a degree of
inaccuracy.
Clöetta and Fischer (1930) supplied a similar map, albeit with
fewer injection sites, for their injections of inorganic salts into the
infundibular region of rabbits, rats and cats; to examine effects on
respiration (Figure 2B). Like Demole (1927), they found that cal-
cium chloride injections produced somnolence. However, Myers
(1974) noted that their large injections (12–50μl) likely resulted
in their entry into the ventricles. Comroe (1943) performed
an extensive study of the hindbrain respiratory center of 115
cats, each anesthetized in a stereotaxic frame so that chemical
injections (bicarbonate, acids, potassium chloride, acetylcholine,
nicotine, strychnine) could be documented in stereotaxic space.
Rather than photograph each injection site (a task not feasible for
so many subjects), Comroe reported the physiological outcomes
of these experiments in the form of a functional map, shown in
Figure 2C. Larsson (1954), who provided the first evidence that
food intake can be controlled through chemical manipulations,
also published the first map of effective feeding stimulation sites
in the brain. In this study, the skull of the subject was first visu-
alized by X-rays to record where the embedded steel needles were
located. Effective injection sites lay posterior to the optic chiasm
and lateral to the fornix (Figure 2D).
2.3.2. Anatomical specificity and central injections
During the late 1960’s and early 1970’s, controversy surrounded
ICI methods from the gradual realization in the scientific com-
munity that centrally injected carbachol and angiotensin II
triggered drinking behavior that, in fact, was not necessar-
ily due to actions within deep brain tissue sites, but because
of actions through the ventricular system of the brain upon
circumventricular structures such as the subfornical organ
(Baxter, 1967; Myers and Sharpe, 1968; Montgomery et al., 1969;
Epstein et al., 1970; Routtenberg, 1972; Singer and Montgomery,
1973; Johnson and Epstein, 1975; Epstein, 1978). Although space
precludes detailed review of the shifting tides of this discussion
during that period of time, the lessons learned from this contro-
versy may be summarized as follows (see also Wise and Hoffman,
1992): (1) anatomical specificity of an injection site requires care-
ful controls, especially since injected solutions can diffuse up
and around the cannula needle and spill into the ventricular
circulation if the needle has traversed through the ventricular
compartment; (2) the injection volume will determine its likeli-
hood of entry into the ventricular system, especially if injections
are near the ventricles; (3) careful “mapping” experiments are
necessary to provide a convergence of evidence that the concluded
“site of action” for a substance is indeed the most sensitive site.
This lesson is exemplified by the discussion in the next section
concerning the locus of noradrenergic actions to produce feeding.
As we shall see, careful cannula mapping studies were conducted
in successive fashion by a few investigators to gradually refine the
map of effective sites where NE injections triggered food intake.
2.3.3. Mapping the feeding effects of norepinephrine (NE)
Following Grossman’s (1960) report (see Section 2.2), the loca-
tions of hypothalamic loci effective for noradrenergic feeding
were refined. Grossman (1962) published a more detailed set of
data concerning the effects of carbachol and NE on feeding and
drinking, respectively; which included a map of effective and
ineffective injection sites (Figure 2E). These sites were plotted
onto Jacob de Groot’s stereotaxic rat brain atlas, first published
for the whole forebrain in August of 1959, and then specifically
for the hypothalamus in December of the same year [de Groot
(1959a,b)]. The atlas plates for the hypothalamus were sampled
at slightly better than twice the resolution of Wendell Krieg’s 1946
atlas (the only other published for the rat brain at the time), and
provided greater detail. (Apparently, Krieg had amore detailed rat
brain atlas he had prepared in 1935, but which he had never pub-
lished; see Krieg, 1975, p. 80). Importantly, Grossman (1962) set
a new standard for mapping the effects of centrally injected com-
pounds into the brain on food intake. Documentation using the
de Groot atlas allowed for reproducibility and re-examination of
the same brain regions by others with greater precision. However,
as for the first report (Grossman, 1960), NE crystals were tapped
into the cannula, preventing precise determinations of effective
concentrations in vivo (see also Routtenberg, 1972; Wise and
Hoffman, 1992).
In 1990, Booth, a biochemist in Neal Miller’s lab, mapped
the effects of centrally injected NE, dissolved in solution, on
food intake. Locations plotted on de Groot plates allowed
direct comparisons to be made with Grossman’s (1962) study
(Figures 2E,F). Booth showed that a hypothalamic region ante-
rior and medial (A6.2, A6.6; Figure 2F) to Grossman’s reported
site (A5.4; Figure 2E) was the most sensitive site for adrenergic
agonists to stimulate feeding. It is unclear whether Booth’s injec-
tion volume (0.675μl) deliveredmore or less NE than Grossman’s
crystal deposits did, but is perhaps a main reason why their
results differ with respect to the site of action for NE. Indeed,
data from Wagner and de Groot (1963) supported Grossman’s
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FIGURE 2 | (A) This drawing is Figure 9 of Demole (1927), which provides
what is likely the first published map of central chemical injection sites for the
hypothalamus. CaCl2 injections were made into the anterior hypothalamus of
cats to produce sleep. The ventral surface of the brain is shown, with
locations of effective (black circles) and ineffective (white circles) injection
sites. Note that the effective injection sites cluster near the optic chiasm and
optic tracts, in the vicinity of the preoptic area and the anterior hypothalamus.
(Continued)
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FIGURE 2 | Continued
(B) Drawing of injection sites near the infundibular region from the study
by Clöetta and Fischer (1930). The labels are in the German language;
injection sites are labeled “Stich.” (C) A generalized diagram by Comroe
(1943) showing functional activation of respiration as a result of injections
of bicarbonate solutions into various hindbrain locations. The responses are
plotted in relation to the sagittal drawing below them to denote from where
the responses were elicited. (D) This drawing is Figure 11 of Larsson
(1954), which shows injection sites where sodium chloride administration
was effective in triggering food intake (white circles with black triangles) or
rumination (black circles with white triangles) in a goat. The injection sites
are mapped with respect to “gross anatomic” visualizable space, as
described in the text. Abbreviations: C. a., anterior commissure; C. f. d.,
columna fornix descendens; Ch. Opt., optic chiasm; C. M., mammillary
body; Hyp, hypophysis with pars post. and pars ant. being the posterior
and anterior pituitaries, respectively. M. i., massa intermedia; T. M., tractus
Meynert; V. d’A. = mammillothalamic tract. (E–G). These maps are from
successive studies (Grossman, 1962; Booth, 1967; Leibowitz, 1978)
attempting to resolve the effective stimulation sites where norepinephrine
produces feeding. The first two maps (E,F) are plotted to the reference
atlas of de Groot (1959a,b) and are directly comparable. In (E), filled circles
are indicative of positive effects of adrenergic and cholinergic stimulation;
white stars indicate cholinergic effects; black triangles represent negative
placements. In (F), effective sites are solid stars; ineffective sites are open
stars. In contrast, the sagittal map (G) furnished by Leibowitz (1978) is from
the atlas of König and Klippel (1963). Numbers on the map in (G) indicate
grams of food intake consumed following an injection in to that site. (H)
Figure 3 of Stanley et al. (1993b) is partly reproduced and shown. The
figure shows a portion of the Paxinos and Watson (1986) reference atlas,
with locations of injection sites (circles) diagrammatically superimposed on
a portion of the atlas plate. Numbers within the circles indicate grams of
food intake following injection of a 10 nl solution containing 78 pmol of
neuropeptide Y into the locations beneath each number. Note that the
numbers on the left hemisphere (in white circles) correspond to 1 h food
intakes following injection, whereas numbers on the right hemisphere (in
black circles) correspond to 4 h food intake scores. (I) A sagittal map from
the atlas of Paxinos and Watson (1998) showing effective feeding
stimulation sites following injections of the μ-opioid agonist, DAMGO, into
the nucleus accumbens by Peciña and Berridge (2005). The scale listed
denotes the color scheme to show increasing magnitudes of food intake
consumed. (J) Cannula placements within the ventral tegmental area
where leptin injections were examined for their ability to reduce food
intake. From Hommel et al. (2006). (K) A map of cannula placements for
mice transduced with Channelrhodopsin-2 constructs within neurons
expressing hypocretin/orexin, included as supplementary material for the
study by Adamantidis et al. (2007). Optical fibers were inserted to
stimulate these neurons and wake mice up from sleep. Blue squares
denote animals with Channelrhodopsin-2 expression; red circles denote
controls that displayed only reporter molecule expression (mCherry).
(L) Camera lucida drawings of locations of hypocretin/orexin neurons in
relation to injection sites locations where NMDA and AMPA stimulated
food intake. From Li et al. (2011). (M) Injection sites in the vicinity of the
ventromedial prefrontal cortex, from Mena et al. (2011), mapped onto
Paxinos and Watson atlas space, where DAMGO injections triggered food
intake. The legend shows the symbols and the amount of food intake
denoted by each. (N) Distribution of ChR2-expressing AgRP neurons in
mice optically stimulated to eat voraciously. The numbers of transduced
neurons are plotted in relation to inferred stereotaxic coordinates to align
their location with mouse brain atlas plates. From the supplementary data
accompanying the report by Aponte et al. (2011). (O) Distribution of POMC
neurons expressing the DREADD, hM4D in a Pomc-Cre mouse, from the
study by Atasoy et al. (2012). The distribution is plotted along Bregma
coordinates using inferred stereotaxic space. All figures are reproduced
with permission of their original publishers, as noted here: Panels
(C and E) (American Physiological Society); (D) (John Wiley & Sons, Ltd.);
(F) (American Association for the Advancement of Science); (G,H,L,M)
(Elsevier/Dr. Brian A. Baldo); (I) (Society for Neuroscience); (J) (Cell Press,
Inc.); (K,N,O) (Nature Publishing Group).
finding that the lateral hypothalamus was a sensitive site, but large
injection volumes (5μl) were used. Using 1.0μl NE, Slangen and
Miller (1969) published histology (but not atlas plots) that gener-
ally confirmed Booth’s anterior and medial locus for the feeding
effects of NE, but also concluded that the perifornical region, in
the vicinity of their injections, was likely to be a sensitive site. In
contrast, Davis and Keesey (1971), who mapped their NE injec-
tions (0.5–1.0μl) using the rat brain stereotaxic atlas produced
by König and Klippel (1963) did not find the perifornical locus
to be sensitive. Leibowitz (1978) published a systematic injection
mapping study in over 500 animals across 35 separate locations
within and outside of the hypothalamus. Using 0.5μl of NE, she
confirmed Booth’s observations that the most sensitive site was
in the medial and not lateral hypothalamus, and further provided
compelling evidence that the area most sensitive was within the
paraventricular nucleus of the hypothalamus (Figure 2G).
2.3.4. Mapping the effects of peptides on feeding behavior
In Section 2.2, selected studies were highlighted that reported the
acute control of feeding by peptide injections. Feeding stimula-
tion sites have been mapped for opioids (Woods and Leibowitz,
1985; Stanley et al., 1988; Bakshi and Kelley, 1993; Peciña and
Berridge, 2000, 2005; Smith and Berridge, 2005; Mena et al.,
2011, 2013), H/O (Dube et al., 1999; Sweet et al., 1999); and
AgRP (Kim et al., 2000), among many others. Similarly, the
feeding-suppressive effects of several peptides have been mapped
or at least partially localized, including bombesin (Kyrkouli et al.,
1987); α-melanocyte stimulating hormone (Kim et al., 2000);
cholecystokinin (Blevins et al., 2000); glucagon-like peptide 1-(7-
36) amide (Schick et al., 2003), and pituitary adenylate cyclase-
activating polypeptide (Resch et al., 2011). Below, NPY feeding
stimulation is examined in detail.
2.3.4.1. NPY and feeding: spatial considerations. Stanley et al.
(1993b) undertook an extensive cannula mapping study to iden-
tify hypothalamic sites sensitive to the orexigenic effects of NPY.
Injections (78 pmol) were made in the very small volume of 10 nl
into 47 brain regions in rats fed to satiety prior to injection, and
food intake was measured 1 and 4 h post-injection. An area cen-
tered on the perifornical hypothalamus at the level of the caudal
paraventricular hypothalamus was identified as a site where NPY
exerted its most powerful effects on food intake, producing about
12.5 g of intake within the first hour. Additional sites near this
locus also displayed strong sensitivity to NPY’s orexigenic effects.
Figure 2H shows some of these NPY-sensitive sites at the level of
the dorsomedial hypothalamus (DMH).
To determine how far 10 nl of injected solution spread to sites
surrounding the injection site, Stanley et al. (1993b) also injected
10 nl of radiolabeled neuropeptide Y ([125I]-NPY) into the peri-
fornical hypothalamus and tracked the anterior-posterior spread
of the injected solution in sections taken at 100μm intervals from
the injection site. Radioactivity from these sections was mea-
sured as a function of both time and distance from the injection.
In addition, an attempt was made to account for 100% of the
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radiolabel in the experiment by carefully measuring the radioac-
tivity in the tissue as well as residual radioactivity associated with
the guide cannula itself. Approximately 95% of the total amount
of radiolabel was accounted for by its presence in the tissue and
cannula, and 100% of the tissue label could be recovered at dis-
tances no more than 0.8mm from the injection site. Importantly,
95% of this label spread to as little as 400μm away from the
injection site (Figure 3). As we shall see in Section 4.4.9, sev-
eral approaches have been used to track the spread of an injected
solution using various labeling strategies. However, this study has
remained unique in using such small volumes to do so, and by
using the same peptide that was producing the observed behavior.
In Section 4, these unique data will be integrated within a spa-
tial analysis of possible neural substrates underlying NPY-induced
feeding behavior.
2.3.4.2. Opioids and feeding: spatial and functional consider-
ations. Studies from the Berridge laboratory delineated novel
feeding-sensitive subregions of the accumbens and ventral pal-
lidum using a variety of carefully designed anatomical validation
approaches. These were based on a novel functional approach
to examine centrally injected chemical solutions first developed
FIGURE 3 | A reproduction of Figure 2 of Stanley et al. (1993a,b,c),
which describes the relationship between the percent recovery of
radiolabeled neuropeptide Y (10nl) within brain tissue 10min
following its injection into the brains of rats. The percent recovery
values are plotted against distance from the injection site in millimeters.
Brain tissue sections were taken at 0.1mm intervals from each injection
site and the amount of radioactive NPY analyzed. The left inset in this figure
(labeled A) shows the same relationship, but with 10, 60, and 240min
recovery times compared. The right inset (labeled B) shows the cumulative
recovery of the radioactive peptide in relation to the distance at which the
recovery was achieved; the numbers indicate cumulative percent recovery
values. Note that the distance scale marks only the spread of the solution
along the anterior-posterior axis, and does not speak necessarily to
movement of the injected solution along any other dimensions.
Reproduced with permission from Elsevier.
by Peciña and Berridge (2000), based on the detection of the
transcription factor, Fos, in neurons following their activation by
stimuli (Morgan et al., 1987; Sagar et al., 1988). The authors rea-
soned that although the diffusion of injected chemical solutions
are difficult to track in vivo, and difficult to infer post-mortem
from an injection site alone, they could track the functional
activation of receptors at the injection site using Fos to mark
neurons actively affected by the injections. Although the Fos tran-
scription factor is a neuronal activation marker, its induction is
not invariably correlated with increases in neuronal firing rates
(Luckman et al., 1994; Watts et al., 2006). However, although
this has not been examined systematically across several different
brain regions, the association between Fos induction and neu-
ronal activation is often assumed to be strong (Fos as a functional
marker is discussed further in Section 4.4.8).
The authors used Fos immunohistochemistry to track neu-
ronal activation in the injection site vicinity, and reasoned that
by “subtracting” from their maps those Fos patterns that did
not correlate with the appropriate behavior, they would iso-
late activation positively linked to the injections producing the
behavior. From their behavioral experiments, they found that
opioid receptor agonist injections into the shell of the nucleus
accumbens triggered food intake. Morphine injections into this
“eating site” also increased hedonic responses to an oral glu-
cose solution, but failed to significantly change aversive responses
to oral quinine infusions. “Fos plume” patterns marked a cir-
cumscribed area of the nucleus accumbens shell where hedonic
reactions to sucrose were enhanced by intra-accumbens mor-
phine. In a follow-up study, Peciña and Berridge (2005) furnished
maps of the sites where hedonic and aversive reactions were
affected by intra-accumbens injections of DAMGO, the synthetic
enkephalin analog that is a μ-opioid receptor-selective agonist
(Figures 1O, 2I). Importantly, for these studies, the authors were
careful to point out that the Fos-expressing cells were not nec-
essarily being activated directly by the injected opioids acting
at opioid receptors on those cells. Indeed, evidence exists for
both excitatory and inhibitory actions of opioids on neuronal
excitability and synaptic transmission in the nucleus accumbens
(Yuan et al., 1992; Chieng and Bekkers, 2001). Opioids are also
capable of exerting disinhibitory actions by inhibiting interneu-
rons synaptically interacting with local circuit neurons, which
are thereby indirectly excited (e.g., see Zieglgänsberger et al.,
1979). These caveats notwithstanding, the activation patterns did
indicate that only a circumscribed set of neurons in the vicin-
ity of the injection site was being recruited by the chemical
injections.
Smith and Berridge (2005) used the Fos plume functional
mapping procedure to examine the effects of opioids on feed-
ing and reward mechanisms in the ventral pallidum. Injections
of DAMGO had differential effects on hedonic “liking” reactions
to sucrose, depending on whether the injections were centered
in the posterior ventral pallidum (increased “liking”) or the
anterior or central ventral pallidum (where “liking” reactions
were suppressed). Similarly, DAMGO increased food intake in a
parallel fashion, increasing feeding in the posterior ventral pal-
lidum, but suppressing it when injected into the other subregions.
Additionally, the authors found that injections of the GABAA
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receptor antagonist, bicuculline, increased feeding at all ven-
tral pallidum sites tested, but failed to enhance sucrose hedonic
responses at any of them.
In addition to these findings, the authors extended the
methodological approach of Peciña and Berridge (2000) in a
number of important ways. First, the authors sought to define
the boundaries of the ventral pallidum by immunohistochemi-
cally labeling the region using antibodies against leu-enkephalin
in three planes of section, which is a peptide enriched in this
region. They opted to document the immunolabeling patterns on
a horizontal atlas level, since this plane of section includes a more
or less complete representation of the ventral pallidumwithin one
atlas section, thereby facilitating a simpler mapping template on
which to plot all of their injections. Second, using the coronal atlas
level of Paxinos and Watson that best fit with the section contain-
ing their injection site, the authors then defined the mediolateral
and dorsoventral coordinates of the injection site off of the coro-
nal atlas level axes (in mm). For the dorsoventral coordinate, the
authors marked their injection sites with ink and then delineated
the “center” of the injection site along the dorsoventral axis as the
midpoint between the bottom of the microinjector needle and the
furthest extent of the ink spread directly below the needle. In this
fashion, they estimated sagittal and horizontal mappings for their
coronal placements, in order to derive three-dimensional maps of
injection site center points. For determinations of the anteropos-
terior atlas level, they noted cases that fell between atlas levels and
chose the midpoint between two levels as the coordinate for the
“between level” sections.
All of these approaches are noteworthy in that they impart
to the reader the serious commitment the authors made in try-
ing to document their placements to the best degree of certainty
(for further details regarding the challenges of mapping these
injection sites, please see Section 4 of Richard et al., 2013). A
few additional improvements notwithstanding, these approaches
stand out for the significance the authors place on experimental
documentation as seen from themultiple sets of information pro-
vided: immunolabeling, ink deposits, Fos plumes, mapping along
one plane of section rigorously, and extrapolations to additional
planes of section. Minor “wish list” items that could have been
added to these excellent approaches include: explicit delineations
by symbols of those placements for which anteroposterior estima-
tions fell between atlas levels (also see the concluding discussion
of Section 4.6.1); tabulated data concerning the deviations of
three dimensional physical coordinates for injection site centers
from true, measured stereotaxic coordinates used to implant the
cannulas; and a representative photograph of a brain section after
ink has been injected. Overall, however, these studies constitute
a signal example of how anatomical considerations can enrich
any functional or behavioral study; indeed, the authors have set
a higher standard by the thoughtfulness of their approach.
2.3.4.3. Using phospho-STAT3 to track microinjected leptin.
Scientists have taken advantage of the fact that the adipose-
derived hormone, leptin, activates specific signal transduction
pathways with molecules that can be used as inducible mark-
ers of activation. For example, the spread of leptin following
its microinjection into specific brain regions can be evaluated
by monitoring the phosphorylation of STAT3 using a phospho-
specific antibody raised against this molecule. Phospho-STAT3
labeling has been observed, for example, following injections of
leptin into the VTA of mice (Hommel et al., 2006).
3. IGI METHODS: APPLICATIONS TO FEEDING CONTROL
AND DISCUSSION OF TECHNICAL ISSUES
3.1. IGI METHODS AND FEEDING
Since the introduction of intracranial gene-directed strategies
to drive expression of specific constructs into the brain using
viral vectors, a number of investigators have used this approach
to examine feeding and other motivated behaviors. Initial viral
delivery strategies incorporated reporter molecules, such as β-
galactosidase, to mark injection sites where virus was delivered
(Davidson et al., 1993; Figure 1K). Table 2 highlights IGI meth-
ods used to study feeding control, including in vivo site-specific
recombinase technology (Balthasar et al., 2005; Donato et al.,
2011; Wu et al., 2012; Zhan et al., 2013) and viral-mediated
expression or RNAi techniques. For example, Hommel et al.
(2006) injected a construct that knocked down the leptin receptor
gene, Lepr, in the VTA and produced altered feeding effects. The
injection sites were carefully documented with respect to tyro-
sine hydroxylase-immunolabeled cell populations of the VTA and
nearby substantia nigra (Figures 1Q, 2J), and also by phospho-
STAT3 activation patterns (Section 2.3.4.2).
More recently developed IGI methods include optogenet-
ics and pharmacosynthetics (Table 2). The first demonstration
of acute, optogenetically-driven behavioral control in a rodent
model was reported by the de Lecea laboratory at Stanford
University, who demonstrated that optogenetic stimulation of
H/O neurons in mice was sufficient to wake them up from sleep
(Adamantidis et al., 2007; see also Carter et al., 2013). Figure 2K
shows their cannula placement map for mice transduced with
Channelrhodopsin-2 (ChR2) in H/O neurons, and control rats
transduced only with the reporter molecule, mCherry; plotted
in relation to the subthalamic region and hypothalamus. Others
have since used optogenetic methods to probe hypothalamic sub-
strates to control other behaviors. For example, the Anderson
laboratory delineated a ventromedial hypothalamic “locus” con-
trolling aggression and documented their optical fiber placements
[(Lin et al., 2011); reviewed by Anderson (2012)]. Konadhode
et al. (2013) also showed that optogenetic stimulation of melanin
concentrating hormone neurons increases sleep. Nieh et al. (2013)
have presented a cogent summary of recent optogenetic work
demonstrating a role for key loci throughout the brain in con-
trolling motivated behaviors.
In relation to feeding behavior, a few studies using optogenet-
ics and pharmacosynthetics have now been published (Table 2),
a few of which will be noted here. Aponte et al. (2011) inserted
ChR2 constructs into AgRP-containing neurons within themouse
arcuate hypothalamus. Activation of the transduced neurons
triggered a robust feeding response. In their study, an opti-
cal fiber placement was documented over transduced neurons
(Figure 1T), and maps of the mouse brain were provided upon
which the total numbers of neurons transduced with ChR2 were
indicated. A summary of these cell counts was also plotted with
respect to Bregma coordinates from the corresponding atlas plates
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Table 2 | Transgenic technologies employed in selected IGI studies on feeding control.
Study Species; construct;
region
Effects observed
TECHNOLOGY 1: in vivo SITE-SPECIFIC RECOMBINASE TECHNOLOGY USING VIRAL INJECTIONS (e.g., cre-lox TECHNOLOGY)
Balthasar et al., 2005 Ms; MC4R; PVH Re-introduced Mc4r in the PVH of transgenic mice lacking Mc4r, resulting in a ↓ BW gain
Hnasko et al., 2006 Ms; CAVCre; DA
neurons
Restored feeding in DA-deficient mice by injecting CAV-Cre (Cre recombinase delivered by a
canine adenovirus vector) into DA terminals in the central caudoputamen, which retrogradely
transported CAVCre to TH+ cells in midbrain and restored TH expression in these neurons
(reviewed by Palmiter, 2008).
Donato et al., 2011 Ms; Lepr ; PMV Lepr restored in PMV of Lepr KO showed no changes in food intake or BW, but ↑ puberty and ↑
fertility; also ↑ uterine weights, cross-sectional area, parenchyma size, and epithelial length; Lepr
restored also normalized the GnRH content in the median eminence and mediobasal
hypothalamus of LepR-null mice.
Wu et al., 2012 Ms; CAV2-Cre;
Tph2; NTS
Blockade of 5HT3R signaling in NTS or Tph2 inactivation in raphe neurons to NTS protects mice
from starvation following AgRP neuronal ablation. Feeding and BW was also partially restored.
Zhan et al., 2013 Ms; hM3Dq, DtR
ARH/NTS
Used Cre-inducible AAV vectors to deliver hM3Dq or DTR to POMC neurons of the ARH or NTS.
See entry for Zhan et al. (2013) under “Pharmacosynthetics” (below), for details.
TECHNOLOGY 2: VIRAL-MEDIATED EXPRESSION OR RNA INTERFERENCE
Dhillon et al., 2001 Rt; leptin; N/A (icv) Delivered rAAV vector with cDNA for encoding Ob gene into the cerebroventricular circulation of
rats. Found ↓ BW gain after two weeks without concomitant changes in food intake; found ↑
uncoupling protein expression in brown adipose tissue and a ↓ in white adipose content.
Szczypka et al., 2001 Ms; TH/GTPCH; CP Delivered viral constructs (TH/GTPCH) for TH restoration in DA-deficient mice coupled with
delivery of GTPC-I, which is essential for producing tetrahydrobiopterin, a cofactor critical for TH
function. This mixed virus treatment in dorsal striatum restored feeding in KO mice (reviewed by
Palmiter, 2008).
Li et al., 2003 Rt; Pomc; (ARH) Overexpression ↑ hypothalamic Pomc in tissue homogenates, with a ↓ in food intake, and a
moderate ↓ in BW gain; this was accompanied by a ↓ in visceral adiposity, fasting serum leptin,
insulin, and cholesterol; and ↑ in uncoupling protein expression.
Kas et al., 2004 Rt; Agouti;
PVH/DMH/LHA
PVH expression ↑ BW and food intake within 7 d; persisted >6wk. LHA expression did not alter
food intake or body weight in rats fed normal chow, but did in rats fed high-fat diet. DMH
expression ↑ food intake and BW with a delayed onset (3wk post-injection). No changes in AgRP,
NPY, MCH, or Hcrt mRNAs.
Noordmans et al.,
2004
Rt; GAD65; LHA LHA overexpression ↓ BW gain and ↓ food intake, with no changes in water intake or feces
production.
Hu et al., 2005 Ms; MCD; (ARH) MCD overexpression ↑ food intake and BW; reversed feeding suppression caused by the fatty
acid synthase inhibitor C75.
Hommel et al., 2006 Rt; Ob-R; VTA Knockdown ↑ food intake, locomotor activity, and sensitivity to palatable food.
Keen-Rhinehart
et al., 2005
Rt; Ob-R; hypothal
(various)/DVC
ARH overexpression ↓ food intake; in all sites except the PVH, overexpression ↑ UCP-1
expression; estrous cycle was normalized and hypothalamic LHRH was ↑ following
overexpression in ARH, MPOA.
Yang et al., 2006 Ms; SIM1; PVH Knockdown ↑ food intake; overexpression ↓ food intake.
Dai et al., 2007 Ms; CPT1c;
(ARH/VMH)
Overexpression ↓ BW gain following a high fat diet.
Gao et al., 2007 Rt; AMPK; (ARH) Overexpression ↑ feeding after 3 d; ↓ i.c.v. leptin feeding and BW suppression; ↓ leptin inhibition
of AMPK; blocked leptin activation of acetyl-CoA carboxylase (ACC), but not STAT3 induction; ↓
leptin from inhibiting AMPK and activating ACC and STAT3 in the PVH.
(Continued)
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Table 2 | Continued
Study Species; construct;
region
Effects observed
Garza et al., 2008 Rt; MC4R; PVH PVH MC4R knockdown ↑ food intake and BW from a high-fat diet, but not after a normal diet.
McCrimmon et al.,
2008
Rt; AMPKa; VMH Knockdown ↓ glucagon, epinephrine responses to hypoglycemia by ∼60 and 40%, respectively.
More exogenous glucose needed to maintain hypoglycemia; endogenous glucose production and
whole-body glucose uptake ↓. ↓ AMPKα associated with faster fall in glucose following insulin
administration.
Yang et al., 2009 Rt; NPY; DMH Overexpression in DMH of lean rats ↑ food intake, body weight and obesity brought on by a high
fat diet; knockdown in DMH ↓ NPY innervation of the dorsal vagal complex and affected CCK
satiation. Npy knockdown in OLETF rats ↓ basally elevated DMH Npy and ↓ BW, hyperphagia,
glucose intolerance, insulin insensitivity, plasma leptin, and triglycerides.
Hayes et al., 2010 Rt; Ob-R; mNTS/AP Lepr knockdown ↑ hyperphagia for chow, high fat and sucrose diets; ↑ BW/adiposity; ↓ sensitivity
to CCK satiation; ↑ basal AMPK activity in mNTS/AP.
Tung et al., 2010 Rt; FTO; ARH/PVH Fto overexpression in ARH ↓ food intake; knockdown to 40% of normal levels ↑ food intake; no
BW changes observed; ↑ ARH gene expression for Stat3 and TH. Fto overexpression in the PVH
↓ food intake, but knockdown did not increase it.
Gao et al., 2011a Rt; mutant CPT1;
ARH
Mutant CPT1 overexpression prevented malonyl-CoA from inhibiting CPT1 but did not affect
leptin-induced anorexia (see Dai et al. above).
Gao et al., 2011b Rt; CPT1c; ARH CPT1c overexpression ↑ feeding, ↑ ARH Npy and Bsx expression; ↓ leptin-induced anorexia and
down-regulation of Npy and Bsx (see Dai et al. above).
Mineur et al., 2011 Ms; β4 nAchR;
(ARH) + MC4R;
PVH
β4 nACHR knockdown ↓ the anorectic actions of cytosine; PVH Mc4r knockdown ↓
nicotine-induced hypophagia, and cytosine-induced hypophagia.
Sousa-Ferreira et al.,
2011
Rt; NPY; ARH Overexpression ↑ diurnal overeating, BW, obesity; associated with elevated circulating leptin and
dysfunctional adipocytes with no changes in POMC immunoreactivity; knockdown did not affect
basal feeding or weight gain but ↓ fasting-induced hyperphagia and locomotion.
Nguyen et al., 2012 Ms; Y1 + Y5
NPY-Rs; PVH
Male and female mice with PVH-targeted knockdown of Y1/Y5-Rs had ↓ food intake to a high fat
diet and various changes also seen in BW, depending on sex and condition.
Zhu et al., 2012 Rt; CCK1-R; DMH Overexpression in OLETF rats had no change in feeding and BW; slight ↑ in daily food intake and
significant ↓ in dark cycle meal size; and ↓ hyperglycemia.
Le Foll et al., 2013 Rt; FAT/CD36; VMH Knockdown did not impair glucosensing, but ↓ number of VMH neurons exhibiting oleic acid
responsiveness; no effect in weanlings on food intake, BW, or adiposity; but displayed ↑ plasma
leptin levels, ↑ subcutaneous fat deposition, and abnormal glucose tolerance.
Zheng et al., 2013 Rt; NPY, DMH Overexpression ↑ food intake caused by ↑ meal size during the dark phase, ↑ BW, and ↓
metabolic efficiency; ↑ high-fat diet-induced hyperphagia, obesity, and hyperinsulinemia.
OPTOGENETICS
Aponte et al., 2011 Ms; ChR2; ARH AgRP neurons ↑ feeding; POMC neurons ↓ feeding, BW; feeding ↑ correlated with AgRP
ChR2 transduction, but not with AgRP neuronal distribution; effect independent of melanocortin
inhibition
Domingos et al.,
2011
Ms; ChR2; VTA Mice chose between licking from either a water feeder coupled to concomitant optogenetic DA
neuron or one that dispensed artificial/natural sweeteners (sucralose and sucrose). Mice chose
DA neuronal over sucralose but not sucrose. DA neuronal + sucralose, however, trumped
choosing sucrose alone. Food restriction enhanced sucrose reward value over sucralose,
whereas leptin reduced it.
Atasoy et al., 2012 Ms; ChR2,
ARH/PVH
AgRP neurons ↑ GABA-mediated inhibition of POMC neurons; POMC neurons overcame
AgRP sy− evoked suppression of POMC neurons; co- AgRP + POMC neurons ↑ feeding and
latency to eat. AgRP axons to PVH but not PBN ↑ feeding. AgRP axons to PVH ↑
GABA-mediated inhibition of PVH neurons. AgRP ↑ lever press break point. Co- PVH AgRP
(Continued)
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Table 2 | Continued
Study Species; construct;
region
Effects observed
axons + SIM1 neurons overcame AgRP inhibition of SIM1 neuronal activity; ↓ AgRP
neuron-evoked feeding. AgRP axons ↓ PVH OT neurons. OT neurons ↑ Fos expression. Co-
AgRP axons + OT neurons ↓ evoked feeding; PVH OT neurons ↓ AgRP- induced feeding.
Blocking PVH GABAA-Rs, Y1-Rs ↓ PVH AgRP axonal -evoked feeding.
Kong et al., 2012 Ms; ChR2,
ARH/NTS
ChR2 expression mainly in PVH axons originating from RIP-Cre neurons in ARH; Rip-Cre axons
in PVH triggered inhibitory post-synaptic currents, ↓ by bicuculline (GABAA receptor antagonist).
ChR2 axons comingled with ventral zone, medial parvicellular PVH neurons displaying fluorescent
beads retrogradely transported from the NTS/dorsal motor nucleus of the vagus. IPSCs observed
after in retrogradely traced neurons. In contrast, AgRP neurons in the ARH transduced with
ChR2 had axons that, when in the PVH, did not produce IPSCs in the traced neurons. NTS
neurons ↑ IPSCs in the raphe pallidus.
Calu et al., 2013 Rt; eNpHR3.0,
dmPFC
(−) dmPFC neurons ↓ stress-induced reinstatement of food seeking, Fos expression, and
electrical activity; but not inflammatory responses in the mPFC.
PHARMACOSYNTHETICS
Krashes et al., 2011 Ms; hM3Dq,
hM4Di; ARH
CNO depolarized and ↑ firing rate of hM3Dq-expressing AgRP neurons in brain slices and ↑ Fos
expression in the ARH. CNO ↑ food intake four-fold in transduced mice in the first 30min
post-injection, with a concomitant ↓ in energy expenditure lasting 8 h. Chronic stimulation using
CNO ↑ BW, food intake. This effect wore off 5 d after withdrawal of CNO administration. CNO
hyperpolarized and ↓ firing rates of AgRP neurons transduced with hM4Di, and ↓ food intake.
AgRP-neuron stimulated mice also achieved higher break points in a nose-poke operant
conditioning paradigm. AgRP neurons in the absence of food ↑ “intense, unrelenting activity”
lasting for hours, indicative of food-seeking behavior.
Atasoy et al., 2012 Ms; hM4D;
ARH/PVH +
PSAM-GlyRs; PVH
+ hM3D; ARH
The hM4D agonist, CNO, ↓ POMC neuron activity in slices, did not alter 1 h food intake in vivo,
but ↓ 24 h intake. CNO ↓ SIM1 neuron electrical activity and ↑ food intake. PSEM silenced SIM1
neurons and ↑ feeding. SIM1 neuronal silencing ↑ lever press break point. CNO-mediated AgRP
activation the ARH ↑ feeding that was ↓ by PVH-applied GABAA-R or NPY Y1-R antagonists but
still above baseline.
Kong et al., 2012 Ms; hM3Dq, ARH CNO depolarized hM3Dq-expressing ARH Rip-Cre neurons in brain slices; CNO ↑ ARH Fos in
Rip-Cre mice, and Rip-Cre, Vgatflox/flox mice. Selective activation of Rip-Cre neurons ↑ O2
consumption and brown adipose tissue activity, but not in mice unable to release GABA (Rip-Cre,
Vgatflox/flox mice) or those not expressing hM3Dq (Vgatflox/flox mice); in contrast, there were no
feeding effects following this treatment.
Zhan et al., 2013 Ms; hM3Dq, DTR;
ARH/NTS
CNO depolarized POMC neurons expressing hM3Dq in the presence of TTX, as well as NTS
neurons; Fos activated in roughly 50% of hM3Dq-expressing neurons in ARH and NTS after CNO
application in vivo. Consecutive CNO injected over 3 d (but not acutely over 1 d) ↓ daily food
intake and BW in mice with ARH hM3Dq expression. In contrast, acute activation of
hM3Dq-expressing NTS neurons ↓ feeding (within 2 h), and ↓ meal number and meal size, and a
second CNO injection prolonged this inhibition for 3 h more (albeit w/subsequent compensatory
feeding). Locomotor activity, in contrast, remained unchanged. DTR expression in ARH ↑ obesity,
BW and ↓ energy expenditure, ↑ body fat, ↓ lean mass, ↑ lipid profiles, hyperglycemia, and ↓
glucose tolerance. DTR expression in the NTS had no such effects.
This is a list of selected gene-directed technologies that have used to examine the central control of food intake: in vivo site-specific recombinase technology;
viral-mediated overexpression or RNA interference (RNAi); optogenetics; and pharmacosynthetics. Symbols used in this table: Middle column: species include
mouse (Ms) and rat (Rt); brain regions include the AP, area postrema; ARH, arcuate nucleus of the hypothalamus; DMH, dorsomedial nucleus of the hypothalamus;
dmPFC, dorsomedial prefrontal cortex; MPOA, medial preoptic area; NTS, nucleus of the solitary tract; with mNTS denoting the medial subnucleus of the NTS; PMV,
ventral premammillary area; PVH, paraventricular nucleus of the hypothalamus; VMH, ventromedial nucleus of the hypothalamus or ventromedial hypothalamus;
and VTA, ventral tegmental area. DTR, diptheria toxin receptor; hM3D, hM3dq, hM4D, and hM4Di are all DREADDs (see text for details). Right column: AMPK,
AMP kinase; AgRP, Agouti-Related Peptide; BW, body weight; ChR2, Channelrhodopsin-2; CNO, clozapine-N-oxide; CPT1, carnitine palmitoyltransferase; d, days;
DA, dopamine; FTO, fat mass and obesity associated gene; GTPCH, GTP cyclohydrolase; h, hours; Hcrt, hypocretin/orexin; IPSCs, inhibitory postsynaptic currents;
MC4R, melanocortin 4 receptor; MCH, melanin concentrating hormone; nAchR, nicotinic acetylcholine receptor; OLETF, Otsuka Long Evans Tokushima Fatty rats;
POMC, pro-opiomelanocortin; TH, tyrosine hydroxylase; TTX, tetrodotoxin; wk, weeks; ↑, produced an increase in a measured variable (e.g., food intake, uterine
weights), stimulated a physiological response, or triggered a behavioral outcome; ↓, produced a decrease in a measured variable, inhibited a physiological response,
or suppressed a behavioral outcome; , optogenetic stimulation; co- , concomitant optical stimulation; (−), optogenetic silencing.
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(Figure 2N), suggesting the use of inferred stereotaxic space, a
concept discussed in Section 4.6.2.1.1. A similar strategy was
employed for an elegant follow-up study from the same labora-
tory [(Atasoy et al., 2012); reviewed by Sternson (2013); Sternson
et al. (2013); see Table 2]. Specifically, the authors showed that
optically stimulated ChR2-transduced AgRP neurons drive feed-
ing responses through inhibition of oxytocin-containing neurons
of the paraventricular hypothalamus. They showed further that
the synthetic and brain-penetrable ligand, CNO, could produce
long-term inhibition of POMC neurons transduced with hM4D,
a DREADD (Designer Receptor Exclusively Activated upon by
a Designer Drug); and that this inhibition also increased feed-
ing. The authors provided distribution data for the rostrocau-
dal spread of their transduced POMC population (Figure 2N).
Although ChR2-transduced POMC neurons are Fos-activated by
optogenetic stimulation (Figure 1U), the authors did not report
the rostrocaudal distribution of the Fos-activated neurons, which
ostensibly would be a subset of the ChR2-expressing popula-
tion. In another elegant study, the Lowell laboratory showed
Fos activation in pharmacosynthetically activated AgRP neurons
(but without a mapped distribution) that was accompanied by
robust feeding (Krashes et al., 2011). Their approach showed,
as did the optogenetic studies, that AgRP neuronal activation
was sufficient to trigger feeding behavior. Finally, Calu et al.
(2013) recently used optogenetic neuronal silencing to exam-
ine feeding control by targeted a light sensitive halorhodopsin
bilaterally to the dorsal medial prefrontal cortex and examined
stress-induced reinstatement of palatable food seeking in female
rats.
3.2. METHODOLOGICAL ISSUES CONCERNING ANATOMICAL
DOCUMENTATION FOR IGI METHODS
3.2.1. Virus transduction efficacy and variability
One important consideration with IGI studies is the extent to
which a neuronal population that is being targeted by a virally
delivered construct has successfully been transduced with this
construct. In rat brain, for example, where the tissue expanse
is larger than that of a mouse brain, multiple injections of a
lentivirus or adeno-associated virus typically are employed in
order to effectively deliver virus to broadly distributed cell pop-
ulations. In such cases, mapping the successfully transduced
neurons is an important documentation procedure that aids read-
ers in independently evaluating the effects of the gene-directed
delivery, whether it is for optogenetic stimulation or silencing,
or knockdown or overexpression of a particular molecule. In
their seminal study establishing the feasibility of adenoviral vec-
tor mediated delivery of a transgene into the brain, Davidson
et al. (1993) used β-galactosidase as a reporter construct within
their vector; the staining for which showed the extent of viral
transduction in the brain (Figure 1K). Similar approaches have
been used for other IGI studies. For example, in their study
(Abbott et al., 2011) of the effects of optogenetic stimulation
on Phox2b-expressing neurons in the rat retrotrapezoid nucleus,
which produced an activation of multiple components of breath-
ing (respiratory rate, inspiration, expiration), Patrice Guyenet
and colleagues not only carefully mapped the locations of all of
their ChR2-expressing neurons across various hindbrain levels,
but did so for all twelve subjects they were examining (see their
Figure 8). This approach nicely illustrates the careful documen-
tation of transduction efficacy that also takes into consideration
inter-subject variability.
3.2.2. Promoter specificity and strength
Yizhar et al. (2011) discuss the types of promoter fragments that
have been used for optogenetic studies. The use of strong pro-
moters over a long period of time may result in ChR2 expression
being associated with abnormal axonal morphology and changes
in the targeting of axons to particular locations (Miyashita et al.,
2013).
3.2.3. Methodological considerations unique to optogenetics or
pharmacosynthetics
3.2.3.1. Optogenetics: inferring connections originating from
single neurons within a stimulated population, and c-Fos activa-
tion. A consideration especially important for optogenetic appli-
cations concerns the degree to which one can gauge the selective
recruitment of transduced neurons following in vivo light stim-
ulation. Just because a group of neurons has been transduced
successfully for ChR2 gene expression does not mean they all
fire with equal fidelity to optical pulses. Those that do may be
intermingled and co-distributed with those that do not. Are the
axonal connections for all optically stimulated or unstimulated
neurons the same with respect to target neurons? The outputs
of subsets of the activated, driven cells may be differential with
respect to the outputs of other subsets. In this regard, Fos activa-
tion studies in vivo following light pulses could help to delineate
activated cells and allow one to infer subpopulations that may be
involved. The data from Aponte et al. (2011) and Atasoy et al.
(2012), for example, demonstrate that a population of arcuate
hypothalamic (ARH) neurons expressing the neuropeptide AgRP
are sufficient to orchestrate robust feeding behavior. The rostro-
caudal distribution of the Channelrhodopsin-expressing neurons
is known from their studies, but the specific neurons along this
axis that were Fos-activated and that produce specific feeding
responses is unclear. Knowing the locations of these neurons
through the rostrocaudal extent of the arcuate hypothalamus
would be very beneficial so as to understand their spatial rela-
tion with other cell populations in the hypothalamus. Similarly,
the delineated distribution and mapping to an atlas of the CNO-
activated subset of Fos-labeled arcuate neurons in the report by
Krashes et al. (2011) would allow others to interrelate those data
with the anatomical locations of activated neurons in their own
experiments.
3.2.3.2. Optogenetics: activating labeled axons. Atasoy et al.
(2012) identified a pathway from mouse ARH neurons to
oxytocin-expressing paraventricular hypothalamic (PVH) neu-
rons with descending connections to the hindbrain. Similarly,
Kong et al. (2012) identified GABAergic “RIP-Cre” neurons in
the mouse ARH that control PVH neurons with descending
projections to the nucleus of the solitary tract to selectively con-
trol energy expenditure without concomitant changes in food
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intake [reviewed by Bouret (2012)]. These studies demonstrated
behavioral or autonomic changes brought about by selective
stimulation of descending PVH connections. Mendelowitz and
colleagues have highlighted how strong promoters are required
to drive ChR2 expression in descending axonal projections orig-
inating from pre-autonomic PVH neurons (Piñol et al., 2012). It
remains possible that weak or inefficient expression of a reporter
molecule accompanying ChR2 expression in axons (e.g., EGFP)
may also result in an incomplete labeling of all axons arising from
transduced neurons. Thus, although reporter expression in tissue
sections distal to the location of transduced cell bodies may allow
for selective fiber-delimited stimulation or silencing, the labeling
of such projections may not reflect the complete set of fibers that
arise from a transduced population. Ideally, one should have data
regarding the locations of axonal projections of a particular group
of neurons prior to designing an optogenetics experiment.
3.2.3.3. Optogenetics: spatial disposition and penetrance of
light. Another issue related to optogenetic experiments is the
need for the experimenter to estimate the degree to which light
is penetrating deep tissue locations such as those found in the
hypothalamus. Recent modeling of ChR2 mediated action poten-
tial generation in cortical pyramidal cells, for example, demon-
strates that the threshold for action potential generation is highly
dependent, in part, on light irradiance (Foutz et al., 2012).
Using a 20-mW 488-nm diode laser on mouse tissue slices con-
taining lateral hypothalamic neurons transfected with ChR2, it
was estimated that 0.5mm3 of tissue receives light of at least
1mW/mm2 (Adamantidis et al., 2007). Laser light delivered by
conventional optical fibers escapes as a cone of illumination with
an intensity that attenuates as a function of distance the light
travels from the fiber tip. Recently, μ-iLEDs have been shown
to provide a more uniform, omnidirectional light delivery than
conventional optical fibers; μ-iLEDs can also be fabricated for
directionally selective light delivery [see Figure 3B in Kim et al.
(2013b)]. Light penetrance in optogenetic applications involv-
ing deep brain stimulation has been addressed at the level of
brain tissue itself. Specifically, the light scattering properties of
mouse brain regions have been estimated in vivo, and a mouse
brain atlas and accompanying software application (http://www.
optogeneticsapp.com) have been created to assist researchers
in designing their optogenetic experiments in a manner that
ensures adequate light penetrance for their target brain region
(Al-Juboori et al., 2013).
3.2.3.4. Optogenetics: thermal changes associated with light
pulse delivery. Blue light laser stimulation to drive ChR2-
mediated depolarization in transduced neurons may give rise to
thermal confounds. Recently, for example, Christie et al. (2013)
reported that rat cortical surface temperatures increased during
blue light (445 nm) laser stimulation, with linear rises in tem-
perature (0.5–7◦C) for light transmitted at powers ranging from
0.6–16mW, respectively.
3.2.4. Summary of technical issues related to using IGI methods for
feeding control studies
To recapitulate the main points of Section 3.2, the locations of
probe placements, transduced neurons, and activated transduced
neurons are all important to document as thoroughly as possi-
ble in IGI studies. Documentation about light and heat pene-
trance for optogenetics studies is also warranted. Documentation
is also important for electrophysiologically recorded neurons
labeled after validation assays using tissue slices ex vivo (often
used in conjunction with IGI methods), which can be mapped
if they are dye-filled or labeled in other ways in relation to
the total population of surrounding neurons. Finally, atlas-based
mapping of circuits probed using IGI methods is fundamen-
tal to establishing legacy datasets upon which to build fur-
ther discoveries. As resources such as Cre recombinase-driver
rats (Witten et al., 2011; see also Sato et al., 2004), certain
ChR2-transgenic rats (Ting and Feng, 2013), and tools such as
Brainbow adeno-associated viral vectors (Cai et al., 2013) gain
more widespread use, then the lessons we have learned so far
using rat models will also remain applicable to these newer
technologies.
3.3. A NOTE ABOUT ICI AND IGI METHODS, FEEDING CONTROL, AND
“CHEMICAL CODED BEHAVIOR”
Before we turn to the next section, which is focused on applying
concepts derived from functional neuroanatomy to feeding con-
trol, it is useful to interrelate ICI and IGImethods in terms of how
they have helped to shape our understanding concerning general
aspects of feeding behavior, such as the way behavior is coded by
complex chemical circuits.
From the early applications of ICI methodology to feeding
control described in Sections 2.2 and 2.3.3, emerged the con-
cept of the “chemical coding of behavior,” which posits that
distinct behaviors can be linked to actions of different chemicals
acting within the same or different brain locations (Grossman,
1960; Miller, 1965). Despite the many benefits derived from using
ICI methods, it is important to note the limitations of such
approaches insofar as what they can tell us about the endoge-
nous operation of chemical networks in the brain. For example,
in the past 25 years, the field of ingestive behavior has generally
paid closer attention to peptides acting to control food intake
rather than small neurotransmitters; in part, because peptides are
easier to localize than small transmitters in post-mortem tissue,
and many have been shown (see Section 2) to acutely stimu-
late or suppress feeding following central injection. However, it
appears from electrophysiological work that the primary ongoing
synaptic activity for the endogenous operation of hypothalamic
and other networks controlling feeding is driven by small neu-
rotransmitters such as GABA and glutamate, and that peptides
may exert a neuromodulatory function superimposed upon their
continuous actions (see van den Pol, 2003, 2012; Marder, 2012).
Thus, the results of behavioral and electrophysiological experi-
ments, along with the interpretations of these experiments by
many investigators, appear to differentially emphasize certain ele-
ments of chemical space and their importance with respect to the
endogenous operations of circuits participating in feeding con-
trol. Nevertheless, scientists have drawn conclusions about the
endogenous or native chemoarchitecture of the hypothalamus
from the effects they observe when certain chemicals, including
proteins, are injected. It remains to be seen whether this “chemical
coding” is a concept that is incorrect, or correct but inaccurately
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and/or incompletely determined by ICI methodology [see, for
example, the criticisms by Booth (1990), p. 474].
Moreover, while it is still too early to ascertain whether newer
IGI methods will completely resolve this issue, they are already
clarifying aspects of it in relation to feeding control. For example,
recent IGI studies (e.g., Atasoy et al., 2012; see Section 3.1) have
identified only a role for GABA co-localized within AgRP neurons
in controlling food intake, but not necessarily AgRP itself. In con-
trast, central injection data indicate that AgRP can trigger feeding
stimulation (Rossi et al., 1998; Hagan et al., 2000; Kim et al., 2000;
Semjonous et al., 2009). Thus, the roles in feeding control for
GABA, AgRP, and NPY (all normally produced within AgRP neu-
rons) have been relatively unclear. This matter was addressed in
an elegant study by Krashes et al. (2013), in which IGI methods
were used to insert DREADDs (see Sections 1.1 and 3.1) in AgRP
neurons of the arcuate hypothalamus within mice harboring sin-
gle, site-specific deletions of genes encoding for NPY, GABA, or
AgRP transmission, or in mice that had triple-gene deletions or
bore double gene deletions (to remove GABA and NPY). The
authors found that CNO-mediated stimulation of these animals
resulted in food intake that appears to rely differentially on all
three molecules: NPY or GABA are required for rapid feeding
and can compensate for each other’s absence, whereas AgRP can
only mediate more prolonged, chronic feeding. The temporal dif-
ferences in the actions of these molecules help to explain their
roles in orchestrating feeding behavior over short and prolonged
time scales. This is one example of how an IGI method (pharma-
cosynthetics), in combination with other transgenic methods, can
help validate and clarify the data produced by ICI and other IGI
(optogenetic) methods to advance our understanding of the role
of various chemical constituents within neural circuits control-
ling feeding behavior. In the next section, we will examine how
thinking about functional neuroanatomy in the context of ICI
and IGI methods can further broaden and deepen our knowledge
and understanding of feeding control.
4. A CONCEPTUAL FRAMEWORK FOR THINKING ABOUT
FEEDING CONTROL SITES IN THE BRAIN
4.1. CENTRAL QUESTIONS FROM CENTRAL INJECTIONS
In Sections 2 and 3, a review of some of themajor central injection
studies examining food intake was provided, with an emphasis
placed on those studies that have included anatomical documen-
tation in the form of injection site locations or maps of such
locations. In this section, we discuss these studies in relation to
a wider view of how injection sites and the neural substrates
controlling feeding and other motivated behaviors can be contex-
tualized in relation to neuroanatomy. Anatomical considerations
are critical in answering three fundamental questions that arise
from the targeted manipulation of neural substrates control-
ling food intake (or any other behavior for that matter). These
questions are:
(1) where is the injection site?
(2) what (and where) are the neural substrates that are affected
by the injected substance?
(3) which, if any, of the affected neural substrates contribute to
the behavior(s) observed?
In evaluating how these questions can be answered using knowl-
edge of neuroanatomy, it is useful to remember that the answers
to these questions (location of the injection site, the location
and identity of the cellular machinery affected by the injec-
tions, and the subset of such machinery that contributes to the
observed behaviors); all reside within the brain. The starting point
to answer all of these questions, therefore, resides in analyzing
the physical substance of the manipulated brain. Traditionally,
this has usually been conducted post-mortem, although non-
invasive functional magnetic resonance imaging (fMRI) of the
living brain in the intact organism has been performed fol-
lowing pharmacological manipulations known to affect feeding
(Stark et al., 2006, 2008; Dodd et al., 2009, 2010). Modified
fMRI and positron emission tomography (PET) methods have
also has been used to obtain real-time data confirming the effi-
cacy of in vivo optogenetic stimulation (Domingos et al., 2011;
Thanos et al., 2013; but see Christie et al., 2013). The state-
of-the-art for these applications, however, is not yet at cellular
resolution.
Remembering that the physical brain itself is the object of anal-
ysis is, on one level, rather obvious. But on another level, the
concept acquires profundity, especially when one asks if all of
the questions posed above for a particular study can be answered
by post-mortem analysis of a single subject’s brain. Does visualiz-
ing the injection site in a selected brain specimen, for example,
methodologically preclude one from examining the affected neu-
ral substrates in the same tissue? If so, then one must resort to
examining certain animals from a given cohort for particular data,
some for the injection site, and others for a view of the affected
neural substrates. But if this latter approach is used, how does one
compare histology from different brains to interrelate these two
distinct sets of data? The questions, then, are reduced down to
those concerning histology; it is therefore worth examining what
happens in this process more closely.
4.2. LOCALIZING INJECTION SITES
“The gains in brain are mainly in the stain.”
—Floyd E. Bloom (1975)
Bloom’s famous adage, which is a useful starting point to begin
our discussion of histological matters, informs us that our under-
standing of the structure of the brain is dependent on the
methodologies used to visualize it. The type of histology per-
formed will, to varying degrees, provide information about the
location of the intracranial manipulation and/or the neural sub-
strates affected by such a manipulation. Consider, for example,
how the studies outlined in Sections 2 and 3 were conducted. The
investigators who performed these studies localized their injec-
tion sites and probe locations in various ways. One approach was
through the use of gross anatomical landmarks, either provided
by the appearance of the skull prior to injection, or from within
the brain tissue itself. For example, recall that Demole (1927)
used dyes such as ammoniacal carmine, Immedial black or India
ink to mark injection sites within the living brain and examine
these sites post-mortem (Figure 1B). In contrast, von Euler and
Holmgren (1956) took X-rays of their cannula implants in the
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skull (Figure 1D) and others (Epstein, 1960b; Grossman, 1960)
used a Nissl stain to see the injection near neighboring groups of
neurons (Figures 1F,G).
4.3. “VISUALIZABLE SPACES” OF THE BRAIN: AN INTRODUCTION
Section 4.4.9 provides more information concerning the diverse
ways in which injection sites have been localized (see Akert and
Welker, 1962 for similar issues for electrode probes). From these
few examples, however, emerges the general principle that the
brain can be visualized in a variety of ways and each of these
ways requires its own special methodology. Although we have
just examined how a few scientists have tried answering the
first of the three questions posed earlier (where is the injec-
tion site?), this principle requires further delineation to help
address this question more fully and to also address the other
two questions which do not concern the location of the injec-
tion site, but deal instead with the neural substrates affected by
the injection.
Figure 4 illustrates a simple formalization of the ideas just
discussed. In panels A and B, basic topological relations are
shown for the skull, the brain it contains, and empirical loca-
tion (injection site, for example) within the brain. Figure 4C then
defines the brain as the sum of all possible “visualizable spaces”
contained within it. Many of these visualizable spaces are topo-
logically distinct, that is, it is not possible to interconvert them.
Thus, an arterial lumen is topologically outside of the brain tissue
proper, even though the vessel may be coursing inside the three-
dimensional volume of the brain mass itself. This topological
relation is analogous to a finger being carefully and slowly pushed
against the taut skin of a gas-filled, transparent balloon: the fin-
ger is outside the balloon but might eventually be seen in “the
center” of the balloon’s dimensions. Thus, angioarchitectonic space
is one visualizable space that is topologically outside the brain
but physically still contained within its dimensions. Although the
unique structural features of topologically distinct visualizable
spaces preclude them from being interconverted, they all share the
common feature of residing within the brain itself. Other spaces
shown in Figure 4C are topologically within the brain and poten-
tially interconvertible with other spaces. For example, functional
space is such a space, since it can incorporate elements belonging
to other spaces, depending on the functional marker used (pro-
tein, mRNA, etc.). Finally, many of these visualizable spaces are
conceptually indistinct. Thus, blood vessels in the brain will inform
both gross anatomic and angioarchitectonic spaces. Fos expression
will inform both functional and chemoarchitectonic (proteomic)
spaces, and so on.
4.4. “VISUALIZABLE SPACES” OF THE BRAIN: A CLOSER LOOK
Before we explore how visualizable spaces can help us organize
our thinking about anatomical localization and registration in
simple ways, it is important to define them more precisely. As
will become evident from the introduction of each of these spaces
FIGURE 4 | A conceptual framework for organizing thoughts
concerning injection site localization. (A) Outline of a rat skull (black
outline only), rat brain (gray), and injection site (gold); showing the
topological relations of these three spaces. The drawing is adapted from
König and Klippel (1963). (B) The topological relations shown in (A) are
simplified in a nested square arrangement here. Note the names given
to each space. (C) A conversion of the relationships presented in (B)
within the context of methodologically visualizable spaces. Stereotaxic
space is derived from skull measures and is therefore listed in the space
corresponding to the location of the skull. This topological relationship
affords stereotaxic space with the privileged position of being a
reference for all other spaces. The space occupied by the brain can be
visualized as any of the spaces listed. Dotted lines signify that each
space is not the only one visualizable; but several can be detected
simultaneously, depending on the compatibility of methods used. See
text for further explanations.
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below, technological developments over the years have allowed
the visualization of certain neural elements to extend from one
visualizable space to another. Table 3 highlights details for stud-
ies mentioned in this section and includes additional references
related to each visualizable space as it has been studied in relation
to feeding control.
4.4.1. Gross anatomic space
Gross anatomic space represents the basic macrostructure within
fixed or unfixed brain tissue, and is defined here as those features
of a whole or sectioned brain that are visible to the naked eye
during a gross dissection. Major landmarks, such as the cerebral
ventricles, major cerebral vessels, and major white matter tracts
are included in such space, and are often used to help delineate the
basic location of the entry of a cannula, injection needle, micro-
dialysis probe, or optical fiber into the brain. A good example of
the effective use of gross anatomic features can be seen in the data
from Eglin (1953) shown in Figure 1C, where simple drawings
of sectioned cat brain indicate locations where acetylcholine and
eserine produced autonomic responses.
4.4.2. Angioarchitectonic space
Angioarchitectonic space is defined as the space occupied by cere-
bral blood vessels that can be used as landmarks to help localize
injections. As illustrated in Figure 5C, angioarchitectonic space
can be visualized with other spaces in the brain.
4.4.3. Myeloarchitectonic and fibrilloarchitectonic spaces
To reflect all methods used, both terms are being included here.
Myeloarchitectonic space is occupied by myelinated axons as they
traverse through brain structures, whereas fibrilloarchitectonic
space, a term adapted here from Brodmann (1909), refers to all
nerve fibers, myelinated, and unmyelinated, within the central
nervous system. Although the hypothalamus is generally thought
to have few myelinated fibers apart from large fiber tracts, a
few investigators have stained myelin sheaths to localize injection
sites in this structure. For example, recall from Section 2.2 and
Figure 1H that the Leibowitz lab employed a method to simul-
taneously visualize cells and myelinated fibers in the same brain
tissue (Table 3). Many investigators have also produced detailed
studies of the myelinated components of the major fiber systems
traversing the hypothalamus (Table 3). More recently, promising
efforts have been made for non-invasively imaging white matter
tracts in the hypothalamus using innovations of basic magnetic
resonance imaging (MRI) techniques (Table 3).
4.4.4. Cytoarchitectonic space
Cytoarchitectonic space refers to the cellular elements in the ner-
vous system that are histologically identifiable from “elemen-
tal” or “cell type” properties (e.g., cell size and shape) or the
more population-based properties for “cell groupings” (e.g., cell
packing and density, regions of lamination, or clustering into
larger nuclei; see Brodmann, 1909, for details). Traditional stain-
ing techniques used to determine cytoarchitecture include those
developed by Golgi (1873) and Franz Nissl in the 1890’s (see
Nissl, 1913). In addition to stereotaxic atlases of the rat brain
that include photographs of Nissl-stained material (Table 4), sev-
eral other Nissl representations of the hypothalamus have been
published (e.g., Bleier et al., 1979). Some investigators, how-
ever, have questioned the importance of using Nissl stains to
establish cytoarchitectonic groupings of nerve cell populations
(see p. 49 of Blessing, 1997). Golgi-stained material has also
been generated for a number of locations in the hypothalamus
(Table 3).
4.4.5. Connectomic space
Sporns et al. (2005) defined the human connectome as “a com-
prehensive structural description of the network of elements and
connections forming the human brain” (p. 0245). For our pur-
poses here, connectomic space is the space in the brain occupied
by its large-scale network of axonal connections. These connec-
tions have been traced using a variety of methods, as summarized
in Table 3. Importantly, IGI methods also involved early stud-
ies demonstrating virus-assisted tract-tracing methods to delin-
eate feeding-related circuits in the hypothalamus (DeFalco et al.,
2001), thereby marking explorations of connectomic space as one
entry point for IGI methods to be applied to feeding control.
4.4.6. Chemoarchitectonic (chemical and proteomic) space
Chemical and proteomic types of chemoarchitectonic space are
usually “visualized” in one of three ways: inferences derived from
actions of a chemical injection, microdissection of tissue, and
immunocytochemistry. Strictly speaking, the first two of these
methods—inferring chemical space from the actions of centrally
injected chemicals or linking molecules analyzed in dissected tis-
sue to locations in the brain—are reciprocally incomplete. In the
first case, numerous studies (some of which were highlighted
in Section 2) have employed ICI methods to deliver chemicals
into brain regions to control food intake. These studies usu-
ally provide (a) the site of injection (i.e., location), and (b) a
record of what the injected chemical did (e.g., behavior, etc.),
but the identity of the endogenous chemical space affected by the
injected chemical is rarely distinct. As discussed in Section 3.3
the concept of behavior as “chemically coded,” which emerged
from this approach, emphasized the anatomical location of neural
substrates underlying the triggering of a complex behavior.
The second method to probe chemical space, which
involves microdissection and homogenization of restricted,
pre-determined locations within fresh or freshly frozen brain
tissue, is incomplete for just the opposite reason: the chemical
information obtained from the tissue is generally accurate, but the
location information provided is limited at best. Strictly speak-
ing, this method is not “architectonic,” since the intact structure
of the tissue itself is not preserved. However, microdissection
atlases (e.g., Palkovits and Brownstein (1988) facilitate catalogu-
ing of chemical space that is anchored to the physical, mapped
structure of the intact tissue itself. In a general sense, then, such
data constitute a form of chemoarchitecture. However, since the
punches are usually quite large and encompass tissue that includes
more than one brain region, it is often difficult to attribute a
chemical constituent of the homogenate as being from a partic-
ular location. Sample sizes become smaller by using laser-capture
microdissection techniques (Table 3).
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Table 3 | The development of visualizable spaces and their use in ICI and IGI studies.
Gross anatomic space
• Reviewed in Clark et al. (1938); see also Christ (1969), Nauta and Haymaker (1969).
Angioarchitectonic space
• Scremin (1970) mapped essential cerebral vessels to stereotaxic space.
• Clark (1938), Finley (1940), Haymaker (1969), Ambach and Palkovits (1979): All are excellent reviews of hypothalamic angioarchitecture.
Myeloarchitectonic and fibrilloarchitectonic spaces
• Weigert (1882) developed stains specific for the myelin sheath (also see Swanson, 2000a).
• Ganser (1882) first described the medial forebrain bundle (basales Längsbündel) in the mole.
• Klüver and Barrera (1953) used Luxol Fast Blue, a sulfonated copper pthalocyanin salt, to stain myelin sheaths.
• Wolf and Yen (1968) combined the Klüver–Barrera stain with Nissl methods (see also cytoarchitectonic space).
• Nieuwenhuys et al. (1982) described the myeloarchitecture of rat medial forebrain bundle.
• Miller et al. (1994), Saeki et al. (2001), and Lemaire et al. (2011) imaged myelinated fibers in human hypothalamus with magnetic resonance or
diffusion tensor imaging (MRI/DTI). DTI is based on restricted H2O diffusion in such fibers (Douek et al., 1991).
Cytoarchitectonic space
• Golgi (1873) developed the “black reaction,” which allowed visualization of nerve cells in their entirety for the first time (see Pannese, 1999).
• Nissl, in the 1890s visualized ribonucleic acids, allowing global visualization of cellular elements for the first time (see Nissl, 1913).
• Brodmann (1909) established detailed parcellation of cortical structures using Nissl stains.
Nissl-based atlases of hypothalamus include Christ (1969) and Bleier et al. (1979).
• Golgi studies of hypothalamus include [see Millhouse (1979), for one overview]: arcuate nucleus (van den Pol and Cassidy, 1982); paraventricular
nucleus: Armstrong et al. (1980); cells associated with the medial forebrain bundle at the level of the hypothalamus (Millhouse, 1969; McMullen and
Almli, 1981)
• van den Pol and Gallyas (1990) introduce a new esterification-silver procedure to induce Golgi-like staining in area of the hypothalamus subjected
to light or severe trauma: light pressure on the ventral surface of the brain is sufficient to induce impregnations of neurons in several hypothalamic
regions.
The ventromedial hypothalamus has been observed using Golgi techniques to apparently undergo dendritic remodeling after food deprivation
(Flanagan-Cato et al., 2008).
• Viruses are developed as tools to produce Golgi-like staining in hypothalamic neurons (van den Pol et al., 2009).
• Variants of the Golgi stain combined with fine histological sampling have been used to provide high-resolution views of the entire brain that allow for
the brain to be “reconstructed” in other planes within three-dimensional space at cellular resolution (e.g., Li et al., 2010; Amunts et al., 2013).
• Glial distribution in the hypothalamus has been reviewed by Polak and Azcoaga (1969). See related reviews by Hatton (2004) and Theodosis et al.
(2008).
• Non-neuronal cell types and their interactions within hypothalamus have also been documented (e.g., Mercier and Hatton, 2000, 2001; Mercier et al.,
2003).
Connectomic space
• Waller (1850) unilaterally severed specific frog cranial nerves, causing their degeneration distal to the injury several days after lesion was made; linked
nerve connection to origin of experimental injury.
• Weigert (1882) applied his myelin stain on degenerating axons.
• Marchi and Algeri (1885) developed a method to stain degenerating myelin selectively.
• Frustrated that the Marchi–Algeri method precludes visualizing unmyelinated fibers (see Nauta, 1993), Nauta and Ryan (1952) developed a reduced
silver stain for degenerating axons rather than degenerating myelin, extending myeloarchitectonic space to fibrilloarchitectonic and connectomic
spaces.
• Taylor and Weiss (1965) and Lasek (1967, 1968a,b) made seminal observations about axonal transport using radiolabeled amino acids.
• Cowan et al. (1972) used radiolabeled amino acid injections and autoradiography to visualize anterogradely transported, radiolabeled proteins in
non-degenerating axons and terminals.
• Kristensson et al. (1971) used horseradish peroxidase to trace connections in either the anterograde or retrograde direction. The method could be
combined with others to yield separate visualizable spaces in the same tissue (see Steward, 1981).
Veening et al. (1982) used the method of Cowan et al. (1972) to identify the topography of the rat medial forebrain bundle, extending
myeloarchitectonic data about this complex fiber system to connectomic space.
• Gerfen and Sawchenko (1984) reported that the kidney bean lectin, Phaseolus vulgaris-leucoagglutinin (PHA-L) was transported primarily in the
anterograde direction, could be deposited in very small volumes, was resistant to degradation, and labeled cells, axons and terminals equally well.
Moreover, PHA-L could be used with other tissue processing methods to help visualize connectomic space with other spaces (Sawchenko and
Gerfen, 1985; Wouterlood and Groenewegen, 1991). For details about tract-tracing, see the excellent volumes by Heimer and RoBards (1981);
Heimer and Záborszky (1989), and Záborszky et al. (2006).
• White et al. (1986) reconstructed serial electron micrographs from all 302 neurons defining the C. elegans nervous system (also see Brenner, 2003).
This massive undertaking is an example, rare at the present time, of how microscopic anatomy can be used to inform connectomic space (for a
discussion of the Brenner lab’s achievement, also see Seung, 2012).
• Petrovich et al. (2005) combined Fluorogold injections in the lateral hypothalamic area with Arc and Homer1a gene expression induced by a
conditioned learning paradigm to identify the projections of neurons activated by cue-induced feeding (reviewed by Petrovich, 2011).
(Continued)
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Table 3 | Continued
• Coolen et al. (1999) developed a co-injection protocol for the simultaneous visualization of anterogradely and retrogradely labeled axonal connections
in the brain; Thompson and Swanson (2010) further elaborated on this strategy by employing two sets of co-injections in the same experimental
subject to delineate closed-loop network architecture in the brain.
• Virus-based transneuronal tracers label polysynaptic pathways (Martin and Dolivo, 1983; for reviews, see Loewy, 1998; Card and Enquist, 1999);
these have been used, for example, to trace sympathetic outflow systems from the paraventricular or lateral hypothalamus (Buijs et al., 2001;
Oldfield et al., 2002; Geerling et al., 2003; Krout et al., 2003), and have been used in combination with electrophysiological recording to identify pre-
autonomic neurons responding to peptides implicated in feeding and metabolic control (Davis et al., 2003). Conditional expression strategies used
in combination with such tracers have been used to demonstrate afferents to the arcuate hypothalamus (DeFalco et al., 2001), efferent connections
from the dorsomedial hypothalamus (Gautron et al., 2010), and pre-autonomic network connections involving the hypothalamus (Card et al., 2011;
Lindberg et al., 2013).
• Cai et al. (2013) have reported the development of Brainbow adeno-associated viral vectors for incorporation of Brainbow XFP cassettes into neurons
by intracranial injection in species other than mice.
Chemoarchitectonic space (chemical, proteomic)
• Forssburg assisted Larsson in analyzing 32P incorporation into punched hypothalamic extracts from hungry and fed goats (see Part II of Larsson,
1954).
• O’Donohue et al. (1979) mapped brain micropunch locations for α-melanocyte-stimulating hormone immunoreactivity.
• Brownstein and Palkovits (1984) mapped brain micropunch locations for radioenzymatic analyses of neurotransmitters.
Khan et al. (2004) examined tyrosine phosphorylation changes in hypothalamic tissue microdissected immediately following central injections of
glutamate receptor agonists.
• Morton et al. (2009) and Li et al. (2011) detected cell phenotypes near injected sites in the ventral tegmental and lateral hypothalamic areas.
Chemoarchitectonic space (genomic, transcriptomic)
• Segal et al. (2005), Yue et al. (2006), and Lee et al. (2012) used laser-capture microdissection/expression profiling to detect hypothalamic transcripts.
• Khan et al. (2007) demonstrated central injection-induced activation of hypothalamic transcripts.
• Watts (1991), Ponzio et al. (2007), and Khan et al. (2011) used intron-based PCR/hybridization to detect hypothalamic hnRNA after stimulation.
• Food deprivation-induced gene expression changes in the hypothalamus have been analyzed using microarrays and/or quantitative PCR (e.g., Ding
et al., 2010; Higgins et al., 2010; Poplawski et al., 2010).
• Single-cell transcriptomics of electrophysiologically identified hypothalamic neurons has also been demonstrated (see Eberwine and Bartfai, 2011).
Functional space
• Gomori, in the 1930s, used histology to track regional brain activation patterns (see Gomori, 1952; van Noorden and Frederiks, 1992).
• Hess (1956) and Thompson (1978) created atlases of those probe sites that produced gain or loss of behavioral function in cats and rats, respectively.
• Sokoloff et al. (1977) used 14C-2-deoxy-D-glucose uptake and autoradiography to track regional activation patterns of the brain.
• Morgan et al. (1987) and Sagar et al. (1988) developed detection methods for immediate-early gene (e.g., c-fos) activation.
• Davidson et al. (1993) employed adenoviral vector gene delivery into the brain, utilizing a functional reporter gene (β-galactosidase) to mark the extent
of the injection site and viral spread in tissue.
• Elias et al. (1998) demonstrated Fos activation in neurons within the arcuate hypothalamus and retrochiasmatic area following peripheral leptin
injections; these neurons were simultaneously traced retrogradely from the spinal cord (i.e., they projected to the spinal cord); this study therefore
combined visualization of connectomic and functional spaces (see also Elias et al., 1999).
• Stratford and Kelley (1999) demonstrated a functional link between the nucleus accumbens shell and the perifornical and lateral hypothalamus
by showing that intra-accumbens muscimol injection triggers Fos expression in these hypothalamic regions. Similarly, Mena et al. (2013) show a
functional link between the opioid-injected prefrontal cortex and the Fos-activated lateral hypothalamus.
• Peciña and Berridge (2000, 2005) examined Fos plumes following opioid injections in the nucleus accumbens. See also Smith and Berridge (2005,
2007).
• Hommel et al. (2006) detected phospho-STAT3 labeling following leptin injections into the ventral tegmental area.
• Khan et al. (2007) detected phospho-ERK1 and 2 in rats given hypothalamic norepinephrine injections.
• Williamson et al. (2010) used androgen receptor translocation to gauge the “spread” of microinjected testosterone into the medial preoptic area of
rats.
• Li et al. (2011) tracked Fos after glutamate receptor agonist injection into perifornical/lateral hypothalamus.
• Aponte et al. (2011) and Atasoy et al. (2012) tracked Fos activation in optogenetically stimulated AgRP and POMC neurons, respectively.
Empirical space
• Demole (1927) visualized ink deposits in relation to anatomical landmarks in brain tissue cross-sections.
• Masserman (1937) used Weil’s myelin stain (1928) to visualize injection sites in relation to myelinated nerve fibers.
• Andersson (1953), Larsson (1954), and von Euler and Holmgren (1956) visualized needles by X-rays in relation to the skull.
• Larsson (1954) used silver staining method of Palmgren (1948) to visualize nerve fibers and nerve endings.
• Epstein (1960b) and Grossman (1960) visualized needle scars using Nissl stains.
• Myers (1966) evaluated the spread of various dyes of differing molecular weights to estimate diffusional distances (see also Swanson et al., 1972).
• Booth (1968) diagrammed gliosis caused by norepinephrine injection (see his Figure 2).
(Continued)
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• Booth (1968), Myers et al. (1971), Leibowitz (1978), Myers and Hoch (1978), and Cole and Sawchenko (2002) tracked injectate with radiolabeled
molecules.
• Swanson et al. (1972) and Stanley et al. (1993b) developed injection delivery systems that minimize the volume (and therefore spread) of injectate
delivered.
• Scammell et al. (1996) and Cunningham et al. (2008) developed injection delivery systems that minimize damage caused by the injector itself.
• Morton et al. (2009) injected Cy3-labeled leptin to evaluate its spread within VTA tissue.
• Atasoy et al. (2012) detected Fos protein expression in neurons stimulated optically within the arcuate hypothalamus of mice.
• Calu et al. (2013) correlated optogenetic silencing of dorsal medial prefrontal cortical (dmPFC) neurons with the absence of dmPFC Fos expression.
• Thanos et al. (2013) have correlated optogenetic stimulation with altered glucose metabolism as visualized by PET.
• Bepari et al. (2012) showed that optogenetic stimulation of striatal neurons resulted in robust mRNA expression of Npas2, Arc, and Egr1 but not
c-Fos.
The information in this table is meant to serve as a supplement to the narrative in Section 4.4 on visualizable spaces and their use in localizing injection and probe
sites in the brain. Certain seminal studies are included that may not relate directly to visualization in relation to injection or probe sites or to feeding behavior per se,
but are important to note for their fundamental contributions to the visualization of the relevant space.
The third (and premier form) of identification that identifies
and preserves chemoarchitecture is immunocytochemical stain-
ing [reviewed by Polak and Van Noorden (1997)]. Although
this method can, in principle, be used for any molecule type
that is immunogenic in an animal, it has been used primarily
to localize proteins in the nervous system, and hence visualize
proteomic space. Numerous studies have used this technique to
visualize feeding-related molecules, axonal pathways, cell popu-
lations, and structural and functional representations of activated
feeding control circuits. These antibody-based techniques allow
for intact preserved tissue sections to retain labeling for key
molecules targeted by the antibodies selected. Importantly, tract-
tracing experiments as well as IGI methods involving optogenet-
ics and pharmacosynthetics can utilize antibody-based methods
to localize tracers, reporter molecules, and activated neurons.
This technique can be combined with counterstaining procedures
to help visualize proteomic space simultaneously with other spaces,
or with in situ hybridization procedures (discussed below) to co-
label molecules in proteomic and transcriptomic spaces (e.g., Khan
and Watts, 2004).
4.4.7. Chemoarchitectonic (genomic, transcriptomic) spaces
Akin to chemical and proteomic determinations, these spaces
are through which chemoarchitecture is visualized at the DNA
or RNA levels. Central injection-induced activation of tran-
scripts has been demonstrated in the hypothalamus (e.g., Khan
et al., 2007; Figure 5). Within the context of feeding behav-
ior, tract-tracing techniques to visualize connectomic space have
been employed in combination with in situ hybridization meth-
ods to visualize transcriptomic space to determine connectivity
between brain regions activated during a conditioned feed-
ing paradigm [(Petrovich et al., 2005); reviewed by Petrovich
(2011)]. Specifically, the authors injected the retrograde tracer,
Fluorogold, into a portion of the lateral hypothalamic area and
observed retrogradely labeled neurons in the prefrontal cortex
and portions of the amygdala. Figure 1P shows the location of a
representative Fluorogold injection site and its careful boundary
delineations as mapped onto atlas plates from Swanson (1999).
Rats traced in this manner and trained to associate food presented
in their cage with an auditory cue (a tone) displayed greater
levels of mRNA expression for the immediate-early genes Arc and
Homer1a in the traced neurons, as compared to traced rats that
did not form this association (control group). This elegant study
provided the first evidence that learning associated with feed-
ing specifically activated forebrain circuits that were connected
directly to lateral hypothalamic substrates implicated in feeding
control.
4.4.8. Functional space
Functional space is defined as that space which contains elements
that become visualizable depending on the behavioral or physio-
logical state of the experimental subject. The study by Petrovich
and colleagues discussed in the previous section is a great exam-
ple of the combined visualization of multiple spaces in the brain:
connectomic, transcriptomic . . . and functional. This is because the
immediate early gene expression in the traced neurons provided
evidence that activation in these cells occurred in association with
a conditioned cue. Under our definition then, the distribution of
these neurons in the brain constitutes functional space since the
activation is associated with a behavioral change. The discussion
in Sections 2.3.4.2 and 2.3.4.3 regarding the Fos plume maps of
Berridge and colleagues, and the phospho-STAT3 activation fol-
lowing central leptin injections, respectively; are also examples
of the use of activation markers to visualize functional space.
Another clever instance of the adroit use of activationmarkers was
reported by the laboratory of Victor Viau, in which they used the
testosterone-dependent translocation of the androgen receptor
from the cytoplasm to the nucleus as an index to gauge the extent
to which testosterone delivered into the medial preoptic area had
spread (Williamson et al., 2010). Figure 1R reproduces a portion
of the data from their study, illustrating the punctate labeling
of the androgen receptor as detected by immunocytochemistry.
Table 3 provides a snapshot of a few additional studies explor-
ing the visualization of functional space in the context of feeding
control and other motivated behaviors. Large-scale efforts are
now underway to map the functional space of the mammalian
brain, as part of the Brain Activity Map project (Alivisatos et al.,
2013).
4.4.9. Empirical space
This space is defined as that which has been physically or func-
tionally affected by the mechanical and chemical forces of the
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FIGURE 5 | Serial sections allow for intra-brain registration of multiple
visualizable spaces. (A) Nissl-counterstained tissue showing the location
of an injection site in the vicinity of the hypothalamic paraventricular
nucleus, as published by Khan et al. (2007). (B) Effects of artificial
cerebrospinal fluid (aCSF) injection (left column) or norepinephrine injection
(right column) on activation of paraventricular hypothalamic neurons. The
first row shows the structures in cytoarchitectonic space (Nissl stain). The
second row shows the structures in functional space (the label is the
activation marker, phospho-ERK1/2). The third, fourth, and fifth rows show
the structure in transcriptomic spaces for the molecules c-fos (mRNA),
CRH (hnRNA), and CRH (mRNA). (C) Adjacent sections from the atlas of
Wünscher et al. (1965), showing cytoarchitectonic (i), myeloarchitectonic
(ii), and angioarchitectonic (iii) spaces for the same portion of the rat
hindbrain. All photomicrographs in this figure were reproduced with
permission from the publishers. (Panels A and B: The Society for
Neuroscience; Panel C: Hirzel Verlag).
intracranial injection itself or the injectate that was delivered, or
both. These spaces are by definition also located within the brain,
but can be considered as distinctly topological. Empirical space
therefore includes any area within the brain that is visualizable
as having been affected by intracranial manipulation. Several
distinct types of empirical space are discussed below.
4.4.9.1. Damaged tissue left by a probe (e.g., cannula, nee-
dle, micropipette, fiber, light) constitutes empirical space. In
Section 1.2, we introduced several possible tissue perturbations
caused by ICI and IGImethods. In the case of ICI, the delivery of a
chemical solution usually causes some displacement of the tissue
and the needle itself leaves a tissue scar that can be visualized,
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Table 4 | Reference spaces for the rat brain using coordinates in stereotaxic space.
Reference spacea Strainb Sexc Nd Weight (s), ge Brainf Sections Photoi APj
Plane (s)g # Ch Thickness Interval
Krieg, 1946 (a) ns 1 237 frs C 29 1mm 1mm N ns
Massopust, 1956 ns ns 30 100, 200, 300 frz C, pS ns 100μm ns N ns
de Groot, 1959a (a) ns >1 200–300 frz/pfn C, S 14 50μm 400μm N I
de Groot, 1959b SD ns >1 200–300 frz/pfn C, S 26 50μm 400μm N I
Morgane, 1961 SDR mf 45 222–254 ns C, H ns 10–15μm ns N I (dG)
Massopust, 1961 W, OM mf >1 200–300 frz C 11 50μm 500μm Y I
König and Klippel, 1963 W f >1 150 frz C, S 56, 9 25, 40μm varies Y I
Szentágothai et al.,
1962
ns m 1 200 cel/pfn C 9 ns 200μm–1mm Y β
Bernardis and Skelton,
1965
SD m 71 50, 100, 150,
200, 250, 300
pfn C ns 12μm ns N I
Albe-Fessard et al.,
1966
W ns >35 200–300 frz/pfn C, S 30 100μm 200–300μm Y I
Fifková and Maršala,
1967
ns ns >1 ns cel/frz C 34 50μm 500μm N I
Pellegrino and
Cushman, 1967
RVH m >1 290–320 (frz) C (dG) 80 40μm 200μm Y I (dG), β
Szentágothai et al.,
1968
ns m 1 200 cel/pfn C 9 ns 200μm–1mm Y β
Valenstein et al., 1969 H mf 91 approximately
7–28
frz C 11 80μm varies N β (KK)
Scremin, 1970 (a) m 60 250–300 frz C 22 300μm 0 (continuous) Y λ
Sherwood and Timiras,
1970
LE f 48 25–30; 50–55;
120–130
frz C, S 78 50μm varies Y I
Hurt et al., 1971 (a) mf 24 270–320 frz C 16 50μm 250μm Y I
Ungerstedt, 1971 ns ns >300 ns frz, fdr C 19 10μm varies (Y) β (KK)
Alegría, 1973 W m 31 175–260 ns ns ns ns ns N λ
Jacobowitz and
Palkovits, 1974
ns m 20 150–350 frz, fdr, pfn C 23 14μm 150μm N I
Palkovits and
Jacobowitz, 1974
ns m 20 150–350 frz, fdr, pfn C 22 10μm 100μm N I
Thompson, 1978 W m >1500 400–650 frz C 14 90μm 500–1500μm Y λ
Heller et al., 1979 H m 1 ns frz C 11 50μm varies Y β
O’Donohue et al., 1979 SD m ns 250–350 frz C 18 60, 300μm varies Y I
Pellegrino et al., 1979 RVH/LE m >1 280–320 frz C, S 99 40μm 200μm Y I (dG)
Paxinos et al., 1980 W m 1 (130) 250–300 H 14 25μm 500μm Y β, I
Slotnick and Hersch,
1980
LE m 1 (14) 345–665 frz C 31 50μm 120–710μm Y I
Simson et al., 1981 (a) ns ns 150 ns H (KK) 0 (12) varies varies Y ns
Paxinos and Watson,
1982
W m >1 270–310 frz C, S, H 76 40μm 500μm Y β, I
Zilles, 1985 W ns 12 350 pfn C, S, H 30 20μm 500μm Y* I (PW)
Schober, 1986 W m 5 300–350 cel C 13 30μm 900–1100μm Y β
Paxinos and Watson,
1986
W m >1 270–310 frz C, S, H 76 40μm 500μm Y β, I
Swanson, 1992 SD m 1 315 cel C 73 30, 40μm varies Y β (PW)
Kruger et al., 1995 SD m 3 320, 328, 387 cel C, S, H 72 20μm 300μm Y β, I
Toga et al., 1995 SD m 1 (6) 270–320 frz C 250–300 100μm 0 (continuous) (Y) β, λ, I
Paxinos and Watson,
1997
W m >1 270–310 frz C, S, H 76 40μm 500μm N β, I
(Continued)
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Table 4 | Continued
Reference spacea Strainb Sexc Nd Weight(s), ge Brainf Sections Photoi APj
Plane(s)g # Ch Thickness Interval
Paxinos and Watson,
1998
W m >1 270–310 frz C, S, H 78 40μm 500μm Y β, I
Swanson, 1999 SD m 1 315 cel C 73 30, 40μm varies Y β (PW)
Swanson, 2004 SD m 1 315 cel C 73 30, 40μm varies Y β (PW)
Paxinos and Watson,
2005
W m 1 290 (c), 270
(s), 290 (h)
frz C 161 40μm 120μm N β, I
Paxinos and Watson,
2007
W m 1 290 (c), 270
(s), 290 (h)
frz C, S, H 161 40μm 120μm Y β, I
Paxinos and Watson,
2014
W m 1 290 (c), 270
(s), 290 (h)
frz C, S, H 161 40μm 120μm Y β, I
This is a list of the major reference spaces, in chronological order, published for the rat in stereotaxic space. Superscripts after column headings denote the following:
athe reference space list does not include those publications which constitute non-stereotaxic atlases; thus, this is only a small portion of the total reference spaces
available for mapping rat brain structures; for full citations for these reference spaces, please consult the References at the end of the article; bfor strain: (a), albino;
H, Holtzman; OM, Osborn-Mendel; SD, Sprague–Dawley; W, Wistar; RVH, Royal Victoria Hospital, LE, Long–Evans; cfor sex, m, males; f, females; mf, both males
and females were used; d for sample size, or N: note that this sample number describes the total number of subjects used as listed by the authors, but does not
necessarily signify that the visual spaces for the reference work were derived from all of these animals; eBody weights are expressed either as a range, or as a single
value for the individual subject used in the reference space. In some cases, weights are specified separately for rats processed for tissue sectioned in the coronal
(c), sagittal (s), and horizontal (h) planes. f for brain condition: fdr, freeze-dried; frs, freshly dissected; frz, frozen; pfn, paraffin-embedded; cel, celloidin-embedded;
in some cases, more than one preparation was included; gPlane(s) of section: C, coronal or transverse; H, horizontal; S, sagittal; pS, parasagittal; sometimes the
plane of section is following that of another reference work, such as de Groot (dG) or König and Klippel (KK); h#C, number of coronal sections in the reference space
(note that 0 coronal and 12 horizontal sections were included in Simson et al., 1981); i Photographs of stained tissue sections either accompanying the reference
space - Y - or not included with the reference space - N - are indicated. (Y), indicates that only a few photographs were provided as a supplement to the reference
space drawings; Y*, designates, for the Zilles atlas, that photographs of stained tissue sections were used as a supplement to, but not as a basis for, the reference
space drawings. The drawings, in turn, are instead based on the original histological material of Paxinos and Watson (1982). j AP, anteroposterior coordinate, based
on either the location of interaural line (I), Bregma coordinates (β), or Lambda coordinates (λ); in some cases the coordinates are based on another reference work,
such as de Groot (dG), Konig or Klippel (KK), or Paxinos and Watson (PW). In all columns, “ns” denotes “not stated.”
often accompanied by gliosis. If the needle was inserted through
an indwelling guide cannula, the cannula itself also causes tissue
damage. Investigators conducting ICI studies often localize the
effects of their injections by documenting the locations of these
tissue perturbations.
In the case of IGI methods such as optogenetics or pharma-
cosynthetics, the process of injecting solutions containing virus
particles results in tissue damage similar to that found in ICI,
especially if the delivery is done using blunt metal needles rather
than glass micropipettes (which typically leave less visible dam-
age; e.g., see Chamberlin et al., 1998). To ensure that a broad
area of the brain receives the efficient delivery of a virus, arrays
of injectors have also been used to deliver viral particles simul-
taneously to several adjacent regions of the same brain (Chan
et al., 2010); such methods will ostensibly leave multiple injector
scars. With certain IGI methods, such as optogenetics, another
tissue perturbation is of the optical fiber used to stimulate or
silence transduced neurons using light pulses. However, recent
breakthroughs in the fabrication of microscale, inorganic light-
emitting diodes (μ-ILEDs) result in intracranial optical probes
leaving much less tissue damage than that left by conventional
optical fibers (Kim et al., 2013b). Another consideration in opto-
genetics is the cellular damage that could be caused by light itself,
especially if pulsed for prolonged periods of time in vivo. In some
situations, when experimental design demands prolonged bouts
of steady illumination, investigators pay special consideration to
this issue by examining cellular markers of damage or inflamma-
tion (e.g., microglia or astrocytes contributing to gliosis) in the
area receiving illumination (Calu et al., 2013).
4.4.9.2. The site of injection is empirical space. In Section 4.2, I
described a few approaches by which investigators have visualized
their central injection sites using ICI methods. Although many
investigators have used stainless steel injector needles to deliver
chemical solutions, a few investigators have opted to avoid both
the greater damage and spread caused by such injectors by using
glass micropipettes drawn to very small tips. A fine example of
this was demonstrated by Scammell et al. (1996), who showed
that 100 nl injections of prostaglandin E2 into the medial preop-
tic area produced fever in rats. Figure 1M shows a representative
injection site from their study, which was visualized in a few ways.
First the injection site was marked by injection of fluorescent
beads. Second, the fluorescence image of the site was superim-
posed digitally onto a dark field photomicrograph of the region.
Very little tissue damage accompanied the injection, and the small
volumes employed helped ensure a finer degree of control over the
localization of effective sites producing fever.
Knobloch et al. (2012) employed a similar strategy when
they reported that optogenetic stimulation of hypothalamic-
originating oxytocinergic projections to the central nucleus of
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the amygdala attenuates fear responses in rats. In their study,
which also examined other locations of oxytocinergic inner-
vation in the brain, the authors carefully document both the
stereotaxic coordinates as well as injection volumes for their
viral injectate within various brain regions, citing the nomen-
clature of Paxinos and Watson. Accompanying these data are
also mapped locations of optical fiber placements within the
central amygdala and a photograph of a glass micropipette
injection site where fluorescent beads were injected at loca-
tions corresponding to where optical fibers were implanted (their
Figure 5A). This is a good example of stereotaxic, diagrammatic
and photomicrographic documentation of optogenetic manipu-
lations. Finally, because neuroanatomical tract-tracing techniques
involve the central microinjection of tracer molecules, empiri-
cal space technically can overlap with connectomic space. This is
because the injection site where tracer deposits are found, along
with all traced cell bodies and axonal connections that contain
exogenous materials (tracer), also technically constitute empirical
space.
4.4.9.3. The area physically exposed to diffused injectate is
empirical space. Empirical space also includes that space which
can be visualized for the purposes of tracking the spread of
injected solutions (see discussion in Routtenberg, 1972), a task
that is probably one of the most difficult challenges when using
ICI methods. Recall from Section 2.3.4.1 that Stanley et al.
(1993b) injected radiolabeled NPY in the small volume of 10 nl
into various areas of the hypothalamus and surrounding regions,
and tracked the spread of this solution in tissue by monitoring
the distribution of radioactivity as a function of distance and
time (Figure 3). Table 3 lists several studies that have included
injections of variously labeled compounds to track diffusion
of injected solutions; in all cases, differences in the molecular
weights and solubilities of the tracking substance (e.g., dye) and
the injected substance of interest (e.g., receptor agonist) should be
taken into consideration, as well as the fact that the local concen-
tration of drug, acting at the final receptive site in vivo is difficult
to estimate, but will be less than the concentration at the injection
site itself.
4.4.9.4. The area functionally affected by diffused injectate:
functional space as empirical space. Finally, as discussed in the
preceding section in relation to functional space, the activation
of the underlying neural substrates affected by an injected solu-
tion can also be tracked, and the extent of this activated area
is used to infer the extent to which the solution has diffused.
As reviewed in Table 3, for ICI methods, these approaches have
included identifying Fos plumes, phospho-ERK1/2 activation, or
nuclear translocation of hormone receptors in neurons under the
injected solution. As discussed in Section 3.2.3.1 for optogenet-
ics, Fos activation following light stimulation also allows one to
infer if light from the optical fiber has affected the excitability of
neurons underneath the illumination, and again renders the use
of functional space as empirical space.
For IGI methods, the viruses injected often carry constructs
that not only encode the engineered construct to be delivered,
but also a “reporter molecule,” such as a histochemically or
fluorescently detectable protein (e.g., β-galactosidase; mCherry,
tdtomato, EGFP). This was demonstrated early in the introduc-
tion of viral vectors as tools for gene delivery (e.g., Davidson
et al., 1993; Figure 1K). When transduced within a neuron, the
presence of the expressed reporter molecule signifies that the
labeled cell has successfully incorporated the sequence delivered
by the virus into its cellular machinery and has presumably also
expressed the engineered construct as a functional protein. The
distribution of the reporter molecule expression within brain tis-
sue is therefore not only an important indicator of the total pool
of neurons that are possibly receptive to optogenetic or pharma-
cosynthetic manipulation, but also allows one to infer the suc-
cessful spread of virus to that location. Noordmans et al. (2004)
adopted this approach for their overexpression of a GAD65 (glu-
tamic acid decarboxylase) construct into the lateral hypothalamus
of rats (Table 2). Their work is exemplary in that they used
reporter molecule expression to estimate both the volume of the
transduced area as well as the error in their stereotaxic proce-
dure, parameters that are rarely included as documentation in
IGI studies. In their optogenetic study of cardiorespiratory activ-
ity in the mouse hindbrain, Abbott et al. (2013) offer a good
example of how optical fiber placements can be mapped care-
fully in empirical space and how these locations can be linked,
using stereotaxic coordinates, to the distributions of reporter-
expressing molecules at these locations documented in functional
and stereotaxic spaces (see their Figure 2). Also, placing reporter
molecule expression patterns in register with the tips of optical
fibers is a useful means to establish the plausible area of the tissue
that would be most likely to receive light illumination from the
fiber (Calu et al., 2013). Similarly, viral-mediated RNAi methods
also utilize the “reporter molecule strategy”; in such cases, cells
expressing the reporter molecule mark their receipt of shRNA
molecules, which then knock down expression selectively in the
transduced cells (Hommel et al., 2003). Viral-mediated RNAi
and overexpression have been demonstrated to affect food intake
when targeted against various molecules in a number of dif-
ferent regions (Table 2). Collectively, these strategies effectively
transform functional space as empirical space.
4.4.10. Summary: visualizable spaces
At a basic, holistic level, this proposed organization of the brain
into “visualizable spaces” is obvious: the brain will contain basic
structures that inform its overall gross anatomy (gross anatomic
space), including blood vessels (angioarchitecture), myelinated,
and unmyelinated fiber tracts (myeloarchitecture; fibrilloarchitec-
ture), axonal connections (connectomic space), cell populations
(cytoarchitecture), including specialized chemical cell types and
systems defined by the expressed, functional proteins and other
small molecules, and the genes and transcripts within these cells
(chemoarchitecture). If one’s intention is to publish as much loca-
tion information about a food intake manipulation in vivo, then
data should be extracted from one or more of these visualizable
spaces once the behavioral component of the study is completed.
Operationally, however, it is usually the case that only one or a
few of these spaces is examined histologically for any single brain
specimen. That is the reason why the emphasis here is to call
these methodologically separable spaces as visualizable spaces: the
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space, although always there, is essentially absent if it is not the
space chosen by the investigator to be visualized histologically or
documented diligently. As we shall see, such choices lead to pro-
found consequences about the limits that investigators place upon
their own studies.
4.5. SEEING VISUALIZABLE SPACES
“Exact information about the functional significance of the deep sec-
tions of the brain is only obtained by working through the brain
histologically in serial section. To avoid far too great delays, the
experiments must be fitted in together as it were in time, and it is
only possible to keep the material collected under control by using a
carefully organized system of registration.”
—Walter Rudolf Hess
Nobel Lecture (1949)
How can we use “visualizable spaces” to address questions about
central injection sites and the neural substrates affected by such
injections? The simplest case is that of histological localization
of an injection site in a single brain, because this allows all
visualizable spaces to be easily placed into anatomical registra-
tion with one another (intra-brain registration). Applying now
the names of the visualizable spaces to our earlier discussion,
using a Nissl stain to mark cellular populations allows one to
visualize the brain in cytoarchitectonic space. The presence of an
India ink-labeled injection site, in contrast, allows us to visualize
the brain in empirical space. Thus, whereas Demole’s ink-stained
injection sites within the unstained brain in 1927 (Figure 1B)
are localizable within empirical space and gross anatomical space,
Epstein’s Nissl-stained injection sites (Epstein, 1960b), which
also contained needle tracks (Figure 1E), are localizable within
empirical space, cytoarchitectonic space, and gross anatomical space.
Similarly, the Klüver-Barrera-stained injection sites (Figure 1G)
in Leibowitz (1975) are visualizable in empirical, cytoarchitectonic,
and myeloarchitectonic spaces, and the β-galactosidase stained
injection site (Figure 1K) within the unstained brain shown in
Davidson et al. (1993) marks functional, gross anatomical, and
empirical spaces. Similarly, fluorescent bead-marked injection
sites in superimposed dark field images (Figure 1M) in Scammell
et al. (1996) are visualizable in empirical and myeloarchitectonic
spaces. In all of these cases, the tissue is being visualized simul-
taneously in two or three separate visualizable spaces because the
methods that allow for such visualization do not interfere with
each other, and all can be applied together to the same tissue sec-
tion (e.g., see introductory comments in Steward, 1981). The use
of these separatemethods to the same tissue section is the simplest
form of ensuring that there is 100% (perfect) registration between
the visualizable spaces, since the tissue for each space is identical.
The issue becomes a bit more complicated if the methods to
localize the injection site within two or more visualizable spaces
are mutually exclusive of one another, or are technically dif-
ficult to perform simultaneously. For example, performing an
immunofluorescence procedure to visualize a particular class of
molecules under a fluorescent microscope may not always be
fully compatible with the tissue processing steps needed to view
Nissl-stained material in the same tissue section using bright field
microscopy. In such instances, collecting adjacent series of tis-
sue sections spaced closely together helps to solve the problem.
Depending on the brain region one wishes to analyze, the degree
of separation between closely adjacent tissue sections is such that
the full extent of a relatively homogenous region is represented
more or less equally within multiple, serially collected sections.
This allows for each tissue section to be processed separately for
each method one desires to use for visualizing the injection site.
Figure 5 shows this for a study in which NE or its artificial
cerebrospinal fluid (aCSF) vehicle was injected near the hypotha-
lamic paraventricular nucleus (PVH) to trigger the expression
of c-fos and corticotropin-releasing hormone (Crh) genes (Khan
et al., 2007). The PVH was sampled within adjacent tissue series
so that at least five separate tissue-processing steps could be per-
formed separately on the same injected region, one for each tissue
series collected. This allowed for the following visualizable spaces
to be examined simultaneously for the PVH in a single brain:
in Figure 5A: (1) empirical space (injection site); in Figure 5B:
(2) cytoarchitectonic space (Nissl series); (3–5) transcriptomic
spaces for c-Fos mRNA, CRH mRNA, and CRH hnRNA (in
situ hybridization series); and (6) functional space (induction of
phosphorylated MAP kinases, pERK1/2; immunocytochemistry
series). Also, Figure 20.5 of Watts and Khan (2013) shows a sim-
ilar set of tissue views for other transcriptomic and proteomic
spaces.
Using serially collected sections that sample one region uni-
formly still allows one to place the visualizable spaces from each
series in registration with one another. Taking again the data
in Figure 5 as an example, if one wished to examine the tissue
series labeled for c-fos mRNA and ask in what brain region is
the mRNA being expressed in response to an injection of NE
in the region, one merely has to examine the adjacent Nissl
series (panel B, top), and conclude that the c-Fos mRNA is in a
region that is co-spatial with the region in the Nissl series that
stains as a densely packed collection of cells corresponding to
the paraventricular hypothalamus. Thus, to draw a conclusion
about the cytoarchitectonic space for a tissue section containing
only mRNA, one can “consult” adjacent cytoarchitectonic space
containing the same brain region. Figure 5C illustrates how neu-
roanatomical reference works often include multiple serial tissue
series for a region, each processed for separate visualizable spaces.
In the case illustrated, which is from a beautiful atlas of the rat
hindbrain by Wünscher et al. (1965), the hindbrain regions that
contain integration structures relevant for feeding and metabolic
control, such as the area postrema and nucleus of the soli-
tary tract, can be visualized in the context of cytoarchitectonic
(Figure 5Ci),myeloarchitectonic (Figure 5Cii), and angioarchitec-
tonic (Figure 5Ciii) spaces. Similarly, the chemoarchitectonic rat
brain atlas of Paxinos et al. (2009) includes stained sections for
seven cellular markers, each from a separate series from a single
brain.
4.5.1. Visualizable spaces within the intact, unsectioned brain:
CLARITY as a solution to the intra-brain registration problem
Recently, the Deisseroth laboratory at Stanford University has
reported the development of a tissue clearing method called
CLARITY, which allows for the selective removal of lipids from
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the intact brain and their replacement by a nanoporous hydrogel
that cross-links effectively with proteins, nucleic acids, and small
molecules within cells; thereby preserving the overall cellular
structure of the brain as a “tissue-hydrogel hybrid” (Chung and
Deisseroth, 2013; Chung et al., 2013). Although the announce-
ment of this new technology is very recent at the time of this
writing, evaluation of the initial reports of its development sug-
gest that the approach has the potential to greatly simplify the
problem of having limited visualizable spaces within the brain
that can be examined simultaneously. For one thing, tissue from
a brain treated by CLARITY does not require sectioning; there-
fore, there are no sections that have to be placed in registration
with one another. However, this is only one half of the challenge;
the other would be to ensure that the brain, if not sectioned into
adjacent series, would still be visualizable withmultiple labels that
would be chemically compatible with one another. This half of
the challenge, too, seems surmountable with CLARITY, as the
technique allows multiple rounds of immunocytochemistry, for
example, to label the same brain structures through the use of
electrophoretic tissue clearing (ETC) (Chung et al., 2013). In
principle, the labeled (and transparent) brain could be imaged
before each new round of labeling, so that the images could
be superimposed upon each other in the same holistic visual-
izable space (which perhaps should be called “clarified space”).
Intra-brain registration issues, therefore, appear soluble using
this technique; however, as introduced in the next section, the
challenge of inter-brain registration may well remain for some
time even for this exciting new technology. Indeed, Chung et al.
note (p. 510): “Turning immense data sets into useful insights
remains a key challenge. Computational approaches to image seg-
mentation, three-dimensional registration and automated tracing
require further development.”
4.6. REGISTRATION OF VISUALIZABLE SPACES WITHIN TWO OR MORE
SEPARATE BRAINS
“A concept (e.g., of a neuron) is the fruit of one’s investigative
approach to an object of nature. If one’s approach had led to knowing
the object, one would possess the truth with respect to it. It is for me
an apriorism that so successful an approach is non-existent: truth is
not to be had. The most we attain is an image of truth: a concept.”
— Hendrik van der Loos (1967)
“The History of the Neuron”
I open this section with the insight of van der Loos, because
the registration of visualizable spaces becomes most powerful if
it can be achieved with two or more separate brains; that is, if
the visualized space in one brain can be “snapped into place”
with a different space in another brain. The benefits of such a
marriage are obvious: data across multiple studies, generated by
separate labs in separate lands, could, in principle, be interrelated
together. Inter-brain registration is a holy grail in neuroanatomy,
the attempted solutions for which have involved complex registra-
tion efforts (e.g., Zitová and Flusser, 2003; Zaslavsky et al., 2010).
Yet, even if we were to somehow place into registration, say, spa-
tial information about an injection site from one brain with the
spatial information provided by neuroanatomically traced neu-
rons corresponding to that location in another brain, the most
we attain is, as van der Loos states, an image of truth: a concept.
This is to emphasize that there is no substitute for empirically
determining your injection site or probe location in relation to
the structures within the same brain. Anything short of this starts
one upon a path of determining placement locations with ever-
increasing sources of error, an idea that will become clearer as
we explore ways to interrelate the visualizable spaces of different
brains. As there are two possible scenarios for inter-brain registra-
tion of visualizable spaces, each with its own challenges, each will
be dealt in turn.
4.6.1. Reference space as a solution to the first scenario
In the first scenario, two visualizable spaces in two separate brains
appear to be in close correspondence with one another but it is
difficult to verify this precisely. For example, the injection sites
from one study may be in similar locations to those in another
study, but differences in the plane of section of the tissue, or how
the tissue was visualized, or how the visualizable space was doc-
umented in the study, or all three factors; may prevent precise
knowledge of this fact. The solution to this scenario, as with many
others like it, is to experimentally map the locations of the injec-
tion sites from one experiment to a reference space (Figure 6A),
and to use the same reference space to map the injection sites
of the second study. Thus, the relation becomes 1:R:2, where the
visualizable space in one brain (1) and another (2) are mapped to
a common reference space (R), as shown in Figure 6B. We have
already dealt with an example of this in the first part of this article:
recall in Figure 2E that the crystalline deposit sites for NEmapped
by Grossman (1962) were in the reference space of de Groot’s
atlas, and the same reference space was used by Booth (1967)
(Figure 2F) to map locations where he had injected the same
neurotransmitter. The de Groot atlas, therefore, serves as one ref-
erence space that permits juxtaposing two datasets generated five
years apart and in two separate laboratories.
The beauty of using a reference space is that it links datasets
in space and time, and the number of possible datasets such a
space can hold is theoretically limitless, especially if the reference
space exists in a digitally extensible format. Table 4 provides a
list of reference spaces, for the rat brain or structures within it,
that take advantage of stereotaxic coordinate space, which will be
discussed shortly. Many of the more recently published reference
spaces listed in the table have vector graphics files, such as atlas
templates, in digital formats to accompany them. These digital
atlas templates are incredibly useful for mapping experimental
data in a reproducible and efficient manner. Although we have
focused on the rat in this discussion, there are many other refer-
ence atlases available that can and are aiding behavioral studies.
Some, such as the Allen Brain Atlas for the mouse (Lein et al.,
2007), are searchable on the web (http://mouse.brain-map.org/),
accompanied by a reference atlas in print form (Dong, 2008), and
are being used as a springboard for new resources for facilitating
IGI studies (e.g., Madisen et al., 2010). High-resolution atlases of
the mouse brain (Li et al., 2010) and human brain (Amunts et al.,
2013) have been published. Reference brain atlases for inverte-
brates also have been created, such as those for the C. elegans
nematode (White et al., 1986; Hall and Russell, 1991), Heliothis,
andManducamoths (Kvello et al., 2009; Huetteroth et al., 2010),
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FIGURE 6 | Reference space, stereotaxic space, and anatomical
registration. (A) A reference space derived from the spatial analysis of a
rodent brain. In this case, the visualizable spaces used to create the
reference space include gross anatomic space and cytoarchitectonic space.
(B) “Scenario One” for inter-brain registration, as described in Reference
space as a solution to the first scenario. Mapping of two empirical locations
(injection sites, for example) from two different brains to a common
reference space. (C) “Scenario Two” for inter-brain registration, as described
in Stereotaxic space as a coarse but viable solution to the second scenario.
Datasets from two different visualizable spaces (empirical and connectomic)
and from two different brains have each already been mapped to two
different reference spaces, respectively. To bring these into registration (at
least along a rostrocaudal axis) requires that they share common stereotaxic
coordinates.
Tribolium red flour beetle (Dreyer et al., 2010), locust (el Jundi
et al., 2010), honeybee (Rybak et al., 2010), and Drosophila fruit
fly (Chiang et al., 2011; Shinomiya et al., 2011; Milyaev et al.,
2012).
Of course, there are caveats with “jumping into” a refer-
ence space: expert knowledge is required to accurately “map”
experimental data to such a space. It is important to remember
that a reference space is originally created from the histological
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examination of a brain or set of brains in a few key visu-
alizable spaces (Figure 6A). Therefore, your own experimental
data, within the brain specimen you have processed, is being
compared to another brain or set of brains. Just as you make
choices about which visualizable spaces to detect in your tissue
sample (e.g., “Should I use a Nissl stain, Weil stain or in situ
hybridization on this tissue series?”), so too, have the authors
in Table 4 made choices as to how to represent their reference
spaces, and on what basis to create such spaces. For exam-
ple, as shown in Figure 5C, for the atlas of Wünscher et al.
(1965), the authors decided to utilize three visualizable spaces:
cytoarchitectonic (Figure 5Ci), myeloarchitectonic (Figure 5Cii),
and angioarchitectonic (Figure 5Ciii).
How does one accurately map experimental data to a reference
space? Extensive discussion of this intricate issue is outside the
scope of this article, but readers can turn to Swanson (2001, 2004),
and Simmons and Swanson (2009); for one viewpoint concern-
ing this topic. Essentially, experimentalists must choose structures
within the visualizable spaces they can view, and utilize these cho-
sen structures as fiducials with which to map their data onto a
reference atlas. Of course, it is highly preferred to plan ahead and
section the material from the completed experiment as close as
possible to the plane of section used by the reference atlas cho-
sen. The preferred fiducial structures to choose in one’s sample
are those basic landmarks that are included in the reference space
as well, which will allow one to match one set of structures to the
other. In making such selections, it is helpful to remember that
it less likely for structures along the midline of the brain to vary
drastically in the left vs. right hemispheres if a transverse section is
sectioned with the intention of keeping both hemispheres similar
in appearance to one another. Thus, “stable” structures such as the
anterior commissure, or midline hypothalamic structures such as
the suprachiasmatic nucleus, paraventricular hypothalamus, and
rostral pole of the arcuate hypothalamus; are good fiducial struc-
tures that can be matched to the corresponding structures in a
reference atlas. Comparing both sets of structures allows one to
determine how close or far in plane the experimental tissue has
been sectioned from that of the brain sectioned for use in the
selected reference atlas. Althoughmapping experimental data to a
reference space is not always straightforward, the rewards of care-
ful effort are that investigators can now interrelate their data with
any other data mapped to the same reference space.
One final note deserves mention about the use of reference
spaces to map probe locations in the brain. Depending on how
the brain used to produce the reference space is sectioned, a cer-
tain interval will exist between sections, which usually can vary for
that space depending on which portion of the brain is sampled.
For example, many atlases typically sample only a small portion of
the olfactory bulb in the rat brain, and show therefore only a few
representative plates from this generally longitudinally invariant
structure. In other parts of the brain, the sampling frequency may
be higher. Because of this, situations will arise when the experi-
menter finds the probe location they wish to map to fall exactly
between reference plates in an atlas. In such situations, a choice
is made to either map the location of the injection to the nearest
atlas plate, or to forego mapping the location for that particular
case. In rare instances, the authors will have access to the original
tissue sections that form the basis of the reference atlas and find
the unpublished section from the original series that falls between
the mapped sections, and have a new map drawn for it (Kelly and
Watts, 1998; Watts and Sanchez-Watts, 2007). To date, this author
is not aware of chemical injection studies that have explicitly indi-
cated on their maps whether they include injection site locations
falling between reference atlas intervals. It is interesting that in
his systematic exploration of electrical stimulation sites within the
brain, Hess would distinguish sites “fitted” to the nearest reference
plates from those “in register” with them through the use of dis-
tinguishable symbols marked on the summary maps themselves
[e.g., see pp. 30–31 and pp. 64–65 of Hess (1957) for a description
and representative maps, respectively, for his symbols]. Perhaps
this practice should be revived.
4.6.2. Stereotaxic space as a coarse but viable solution to the
second scenario
In the second scenario, two visualizable spaces in two separate
brains have been mapped to two separate reference spaces, and
the experimentalist does not have access to the original tissue
sections for either brain, just the maps within the two separate
reference spaces. Thus, the relations are, 1:R1 and 2:R2—where
1 and 2 are visualizable spaces from two separate brains and R1
and R2 are two different reference spaces. How does one reconcile
these separate datasets? In this case, somethingmust tether one set
of data to the other. Fortunately, if both reference spaces contain
information from stereotaxic coordinate space, such information
could provide the tether needed to link the datasets (Figure 6C),
provided that certain conditions are met.
4.6.2.1. Stereotaxic space. This is the only visualizable space dis-
cussed so far that is not residing in the brain per se, but is usually
considered before intracranial manipulations are made in the live
animal, when a stereotaxic atlas is consulted. Notice in Figure 4C
its privileged position as a “visualizable space” surrounding the
brain’s other visualizable spaces, in relation to the complementary
position held topologically by the skull (Figures 4A,B). Table 4
provides a list of stereotaxic atlases or individual stereotaxic stud-
ies for the rat. Stereotaxic space is three-dimensional space that
is calibrated using skull reference points that, for the most part,
do not change drastically so long as subjects fixed within the
stereotaxic frame fall within a body weight range similar to that
for the subjects used in the stereotaxic atlas (e.g., Paxinos et al.,
1985), and the atlas ‘horizontal plane’ is used to place the subject
in a similar orientation using the incisor bar of the stereotaxic
instrument.
4.6.2.1.1. True vs. inferred stereotaxic space. Before an experiment,
stereotaxic space is “visualizable” insofar as the movement of the
stereotaxically held probe is concerned during the course of an
experimental manipulation. This is when the coordinates are used
to move glass pipettes or other delivery devices to deposit tracers,
toxins, viruses, or chemical solutions (or implant chronic can-
nulas, microdialysis fibers, carbon fibers, electrodes, or optrodes,
etc.) into pre-determined target locations based on Cartesian
coordinates calibrated from surface features of the skull, which
serve as “zero” points of origin. I refer to this as true stereotaxic
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space. After an experiment, stereotaxic space remains useful for
estimating the position of histological material as it may have
appeared in the original coordinate space, thereby allowing visu-
alizable material to be mapped to a stereotaxic atlas. Of course,
other criteria are needed to map such material, but the post-hoc
invocation of an estimated coordinate in the anteroposterior axis,
for example, is useful for basic registration purposes. I refer to
this as inferred stereotaxic space (i.e., that which was not truly
measured using a stereotaxic instrument firsthand).
True stereotaxic space may still play a role after an experiment
under a few conditions. First, positional needles can be inserted
into the brain, while it is still in the skull and the skull is in the
stereotaxic instrument. The needles can be inserted in various
orientations, and if their complete tracks appear during tissue
sectioning, the experimenter knows that the tissue is being cut
in register with the needle’s original orientation (e.g., Paxinos
and Watson, 1986). Thus, a full-length needle track appearing on
the face of the tissue block marks the correct plane of section.
Although the tissue is being processed after the experiment, it
retains a mark of something positioned in true stereotaxic space.
Second, brains can first be sectioned in stereotaxic space by keep-
ing the skull in the stereotaxic instrument, chipping away the
dorsal surface of the skull to expose the brain, and then using a
blade fitted within the stereotaxic manipulator arm to produce
large slabs of the brain at fixed intervals. For example, Burke et al.
(2009) have used this method for the brain of a non-human pri-
mate. A slab could be cut further on a microtome to produce
thinner sections that are parallel to its cut surface (Ireland and
MacLeod, 1993).
Figure 7 illustrates tissue sections that exemplify both out-
comes of stereotaxy: true and inferred. In Figure 7A, a portion
of Plate 31 from the 1998 Paxinos and Watson atlas is shown,
which has been sectioned “in plane” to the remaining atlas as seen
from the needle track in the tissue that runs more or less contin-
uously through its dorsoventral aspect on one side. Plate 31 was
sampled at a Bregma coordinate of −2.80mm; that is, 2.80mm
behind the Bregma suture on the skull. In contrast, Figure 7B
shows a portion of immunohistochemical labeling for the Y1
subtype of the NPY receptor family in rat brain tissue, which
was published by the Hökfelt laboratory (Kopp et al., 2002). The
image was photographed under dark field illumination and the
bright white labeling marks the immunoreactivity. Notice that
in the upper right corner of this figure is a pair of coordinates:
“−2.85v/−3.25d”; which indicate that the lower portion of the
section is estimated to be in a transverse plane located 2.85mm
posterior to Bregma, whereas the dorsal portion of the section
would be in a plane 3.25mm posterior to Bregma. Clearly, the
section was not cut a priori to align itself uniformly with any
one level of a reference space, but the authors were careful in not
only trying to helpfully provide inferred stereotaxic space infor-
mation for this section, but to distinguish between differences
in plane between the upper and lower parts of the section. This
valuable information allows a reader of their report to indepen-
dently align this labeling pattern to a stereotaxic reference space
of their choosing. For example, consulting these inferred coor-
dinates against the rat brain atlas of Swanson (2004), one can
conclude that this tissue section falls somewhere within levels 28
and 29 of that atlas.
The distinction between true and inferred stereotaxic space is
not simply semantic. The use of the word “true” for one space is
not meant to indicate the other as “false”; indeed, both are equally
useful depending on the situation. Moreover, both are just as eas-
ily prone to be inaccurate because of methodological error. The
major differences, however, are the sources of the error for each
type of space measure. For true stereotaxic space, incorrect probe
or needle movements in any one of the three dimensions will
throw a coordinate off its true mark. Many factors can make the
final probe location vary from the intended location. For exam-
ple, differences between the size and age of the animal used in
one’s study relative to that used for the reference atlas being con-
sulted can introduce errors in stereotaxic placements. In the case
of inferred space, the within-tissue patterns of labeling and fidu-
cials that one uses to infer positional information is a matter of
correct interpretation; incorrect judgments can introduce error
to the estimate.
Thus, true stereotaxic space is space that is being navigated
before and during the journey, when the ship’s captain is “plotting
a course” and “holding course”: in such cases, poor navigation
and a failure at course correction will render the ship off course.
In contrast, inferred stereotaxic space is unnavigated space that is
being assessed after the journey has been made: in these cases, a
failure to estimate one’s position based on landmarks at the des-
tination (azimuth, compass heading, coastlines) will result in a
grossly overestimated or underestimated final position. Examine
both panels of Figure 7 closely: from the tissue alone (ignoring
labels and needle track), one does not necessarily know if (a) the
stereotaxic space wasmeasured; or (b) if it wasmeasured, whether
it is true or inferred. Generally speaking, details about the meth-
ods must provide that information (e.g., see Noordmans et al.,
2004; discussed in Section 4.4.9.4). If they do not, the data are
not so easily interpretable with respect to stereotaxic space. When
interpreting an injection site location, it is critical to know how
the location was measured, so as to be aware of the types and
sources of error for the measurement.
4.6.2.2. Stereotaxic coordinates in publications protect location
data. Information about stereotaxic coordinate space is critical to
document alongside any dataset for which a precise localization
of a probe, injection, or field of affected cells is needed, especially
if the atlas used in conjunction with the coordinates falls out of
common use over time, or if data from other types of visualizable
space are not included in a publication containing the dataset.
This is because the stereotaxic measurements are with respect to
skull surface landmarks that are independent of the atlas being
used. This fact has enormous implications: the proper documen-
tation of coordinates within a publication prevent the anatomical
data of an injection study from become un-interpretable by allow-
ing for the locations of the injection sites to potentially be placed
in register with a more current stereotaxic atlas. Since the newer
atlas also is calibrated with respect to skull landmark position,
the inclusion of coordinates for stereotaxic space within the older
study could potentially liberate its data, preventing them from
languishing in a reference space that few people use any longer.
4.6.2.3. Atlas registration. Returning, then to the second sce-
nario discussed earlier: 1:R1 and 2:R2; two separate visualizable
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FIGURE 7 | True vs. inferred stereotaxic space. In (A), which is a
coronal section from a plate in Paxinos and Watson (1986), an example
of tissue visualized using true stereotaxic space is shown. The needle
track marks the location of a needle traversing the section through its
cut plane while the subject was placed in a stereotaxic frame. (B) In
contrast, stereotaxic location is only inferred in the histochemical
labeling of the NPY Y1 receptor by Kopp et al. (2002). Note in the
upper right corner the coordinates listed in relation to the dorsal or
ventral aspects of the tissue section. Both panels reproduced with
permission from Elsevier.
spaces, mapped in two separate reference spaces, can be placed
in registration with one another by using stereotaxic coordinates
that both reference spaces can relate to. However, this is possi-
ble only if certain conditions are met. For example, if R1 and R2
both have atlas plates that are calibrated to Bregma (the reference
point on the skull surface where the coronal and sagittal sutures
intersect), then they are potentially registerable with one another.
Another critical factor is whether the basic angle of the surface of
the skull with respect to the horizontal plane of reference used by
each reference space is similar for both R1 and R2.
Figure 8 presents a system for registering two families of atlases
for the rat brain that have been in popular use: those published by
Paxinos and Watson (1982, 1986, 1997, 1998, 2005, 2007, 2014)
and Swanson (1992, 1999, 2004), hereafter referred to as PW and
S, respectively. For the following descriptions, the reader is asked
to refer to the left side of Figure 8. The PW atlases actually fall
into two subgroups: PW1 refers to the first four editions of the
atlas (1982, 1986, 1997, and 1998; PW82, PW86, PW97, PW98,
respectively) all of which contain the same histological dataset
(i.e., they all use the same brain tissue from the same subjects).
Each new edition in the PW1 grouping is an improvement upon
the previous edition in important ways: PW86 and PW97 contain
a revised nomenclature over PW82, PW97 and PW98 include two
additional atlas plates that were not included in PW82 and PW86.
In contrast, PW05, PW07 and PW14, which form PW2 reference
space, are based on a completely different rat brain, one processed
to create the atlases anew.
The upper scale in Figure 8 is in millimeters rostral or caudal
to the skull suture landmark, Bregma. Two sets of comparisons
are made. In the upper panel, PW1 reference space is compared
to S reference space, with atlas levels for these spaces marked by
dots aligned along the Bregma scale to the nearest hundredths
of a millimeter. Thus, PW82 and PW86, which share the same
numerical scheme for atlas level numbering, are shown along the
top row, with identical dots for their levels. The inclusion of two
extra plates in PW97 and PW98 shifts the atlas level numbering
scheme by two, thereby requiring a separate row of dots alongside
PW82 and PW86 (with the new plate additions noted by blue
dots). Finally the lowest row in the upper panel is for S92, S99,
and S04 atlases of S space, all of which are from one brain and
share the same numerical atlas level designations. In the lower
panel, the same system has been constructed for PW2 reference
space in comparison to S space (which is reproduced from the
upper panel).
The final set of information that allows for the reader to inter-
pret the chart in Figure 8 is about the dot symbols themselves.
One reference space’s levels (colored dots) need to be seen in rela-
tion to the other reference space’s levels above or below it. Red
dots signify atlas plates between PW and S spaces that are not in
register with one another with respect to the Bregma coordinate.
Black dots, in contrast, represent atlas levels in each space that are
fully in register with one another by Bregma coordinate, out to the
hundredths of a millimeter. Finally, white dots denote atlas levels
within 50μm of one another, i.e., narrowly in register.
A few observations can be made about these alignments. First,
the outer diameter of a 33-gauge needle (typically among the
smallest used for ICI methods) is 120μm. Optical fibers for use
in rats are typically between 100–500μm in diameter (Zhang
et al., 2010). Thus, the resolution of the atlas level registration
conducted here between the reference spaces is well within the
resolution of a single optical fiber or cannula needle, or recently
developed μ-iLED-based semiconductor probes (with integrated
assemblies being 200–400mm wide; Kim et al., 2013b). The res-
olution is also far greater than the diameters of optical imaging
probes (∼350μm) being developed for deep, direct visualization
of hypothalamic and other structures (Kim et al., 2013a), and
about the same order of magnitude as the diameter of a glass
micropipette delivering virus or tracer (typically 10–50μm).
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FIGURE 8 | Continued
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FIGURE 8 | A reference chart to align ten canonical rat brain atlases
along a uni-dimensional coordinate. (A) PW1 Levels = Atlas Levels from
Paxinos and Watson Reference Space 1. This reference space consists of
atlas levels from the first four editions of The Rat Brain in Stereotaxic
Coordinates by George Paxinos and Charles Watson, published in 1982,
1986, 1997, and 1998 (designated PW82, PW86, PW97, and PW98),
respectively. Editions 2–4 contain refinements of the atlas drawings in the
first edition, but the actual tissue sections on which the drawings are based
are the same as those used in the original edition. ∗The only exception to this
rule is that PW97 and PW98 differ from PW82/86 in the addition of two levels
from the original tissue set that had not been published in the earlier editions.
These are highlighted as blue-colored dots. Because these additions alter the
numbering scheme for the PW97 and PW98 levels from those of previous
PW editions, they have been displayed separately from those editions. (B)
PW2 Levels = Atlas Levels from Paxinos and Watson Reference Space 2.
This second reference space for Paxinos and Watson consists of atlas levels
from the fifth, sixth, and seventh editions of The Rat Brain in Stereotaxic
Coordinates by George Paxinos and Charles Watson, published in 2005, 2007,
and 2014 (designated PW05, PW07, PW14), respectively. They are in a
separate reference space because the tissue used was from a different
animal than that used for the earlier editions, which were actually based on
tissue sections from several animals. For both panels (A,B): S Levels = Atlas
Levels from Swanson Reference Space. This reference space for Swanson
consists of atlas levels from all three editions of Brain Maps: The Structure of
the Rat Brain by Larry W. Swanson, published in 1992, 1999, and 2004
(designated S92, S99, and S04), respectively. They are all within one
reference space because the same tissue set has been used for each edition,
with the editions differing primarily in the refinement of the drawings from
this single tissue set. The atlas levels in PW1 or PW2 can be aligned with
those in S space along the anteroposterior axis using a millimeter scale based
on the skull suture landmark, Bregma. Atlas levels from PW1 or PW2 space
that are in 100% registration along this dimension with a corresponding level
of S space shown directly below it are depicted by a black dot (signifying
“fully in register”). Those levels of PW1 or PW2 space that are within 50μm
of corresponding levels in S space are marked as white dots (with black
borders). These levels are “narrowly in register” with one another. Finally,
those levels between PW1 or PW2 spaces and S space that are greater than
50μm apart are marked by red dots as “not in register.” See text for details.
Second, although details of this are being readied for pub-
lication elsewhere, key fiducials (tissue landmarks) within atlas
photomicrographs of Nissl-stained sections corresponding to lev-
els marked by “black” dots, which represent levels between the
two atlas systems that are in full register with one another, appear
to match up very well. Thus, two sets of structural information,
one dependent on the planes of section and nearest neighbor rela-
tions within the tissue (fiducials), and the other independent of
the brains (stereotaxic coordinates along Bregma), are consistent
with one another and serve as a validation of this arrangement
(Wells and Khan, 2013). Third, notice how levels in PW2 space
are much more closely spaced than those in PW1 space: this is
because tissue was sampled every 120μm from the brain used to
create the atlas in PW2 space; therefore, there is slightly more than
twice the sampling frequency for PW2 over PW1 space. A conse-
quence of this is that the ability to register levels of S space changes
with respect to the two PW spaces: notice how more S levels are
red (“not in register”) alongside PW1 levels, than when they are
alongside PW2 levels. The greater sampling frequency of PW2
space allows for greater amounts of data between the two atlases
to be in register with one another, underscoring the interdepen-
dency of different reference systems as they evolve and improve
over time.
A major limitation of this atlas interconversion system is that
it is only valid along one dimension of the three-dimensional
Cartesian system that represents stereotaxic space. This is a criti-
cal point. Indeed, the mediolateral and dorsoventral dimensions
between the two brains are very different, since the brains were
histologically processed in different ways for each reference space
(Wells and Khan, 2013). In PW atlases, the brains were frozen and
then sectioned; in S space the brain was embedded in celloidin
and therefore underwent a shrinkage that requires correction
factors in both of these dimensions (the reader is referred to
the front matter of the atlases for details about these processing
steps). As noted by Swanson (2001), S space was actually aligned
and linearly rescaled to be placed in register with PW space in
the anteroposterior dimension; it is this rescaling that allowed
stereotaxic coordinates to be inferred for S space [see pp. 173–174
of Swanson (2001)]. Thus, PW space is true stereotaxic space, and
S space is inferred stereotaxic space based on alignments and linear
re-scaling of S space to PW space. This alignment and rescal-
ing is possible because the two reference spaces are based on
brains cut in very similar planes of section, using the brains of
relatively similar sized rats (albeit different strains). Importantly,
this conversion system allows for only a somewhat coarse atlas
registration along the rostrocaudal coordinate for studies that
have probe placements in the dimensions specified above. True
reference space inter-registration requires computational power,
a topic that has received much attention in the field of brain
imaging (e.g., see Toga and Thompson, 2001).
4.7. TO MAP OR NOT TO MAP?
“The constraint of organized life offers a better approach to truth
than does an uncontrolled imagination.”
— Jean-Paul Schaer (1987)
The Anatomy of Mountain Ranges
There are perfectly defensible reasons why atlas-based approaches
in neuroanatomy are not necessary for gaining an understand-
ing of the location of probe placements or elements forming
neural circuits underlying behavioral control. Armedwith aNissl-
stained tissue series and a simple camera lucida set-up, one can
describe with great accuracy where one’s placements might be
located in the brain and how these placements are related to sur-
rounding populations of neurons. In some ways, representing
histology through camera lucida drawings or photomicrographs
of the stained tissue itself more accurately represents such data
than a “reference map” would. However, as we shall see, a lim-
itation of this approach is that it is very difficult to participate
within a community-based effort to understand complex neural
circuitry without placing one’s dataset within a reference space
that allows for inter-brain registration of data and for sophis-
ticated databasing and computational tools to be brought to
bear on the shared datasets. To be sure, mapping raw data to a
reference space is an act of transformation that necessarily ren-
ders them into a form that is constrained by the interpretations
inherent in the parcellation schemes of the reference space itself.
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But so long as the scientific community understands that a map of
such data in reference space constitutes a data-constrained model
of how circuits controlling behavior might be organized, which
leads to one being able to test the model and refine it, then the
approach has great merit. Of course, a conceptual model can be
formulated without mapping to a reference atlas, but the model
is based solely on the accumulated informal understanding by
scientists of the locations where behavioral effects occur across
multiple studies, without actually having the data from those
studies integrated together formally (i.e., conventional wisdom).
One therefore can easily suppose that a traced circuit in one study
might be involved in feeding control, based on examining the
injection sites in another study. Atlas-based data integration con-
strains and tests such suppositions so that a shared conceptual
model becomes a shared data-constrained model, thereby allow-
ing what is known about the organization of the brain itself, as
Schaer notes above, to limit the “uncontrolled imagination” about
how such organization might look like. In the next section, I dis-
cuss how data integration could allow for new insights to form
and new hypotheses to be constructed that are constrained care-
fully by the shared information provided by accurately juxtaposed
datasets.
5. PROPOSAL: TOWARD A COMMUNITY-BASED
UNDERSTANDING OF FEEDING CONTROL CIRCUITS
In 1854, the English physician John Snow made history in the
fields of epidemiology and medical geography by superimposing
two seemingly unrelated location datasets of the Soho district of
London upon one another. The first dataset was on a map and
consisted of locations of the water pumps distributed throughout
the neighborhood. The second dataset was his tally, by street, of
the number of deaths in each household within that neighbor-
hood, brought about as a result of a devastating cholera outbreak.
While the mode of transmission for cholera was still believed to
be airborne, Snow had long felt that the illness was transmitted
through water: the superimposed locations of the water pumps
and deaths served to illustrate this convincingly. He published
his “spot map” (Dean, 1976) to illustrate his prior conclusions,
providing visual evidence that the source of the outbreak was the
Broad Street water pump (Brody et al., 2000; Johnson, 2006). The
lesson here is that superimposing different datasets onto a com-
mon reference space can help communicate important insights
about biology, or in Snow’s case, pathobiology.
In the preceding sections, I have made the case for the close
examination of neuroanatomical data within central microin-
jection studies. I first reviewed this field in Sections 2 and 3
highlighted ways to contextualize these studies within a theo-
retical framework of “visualizable spaces” in Section 4, and also
discussed in Section 4 how intra-brain and inter-brain registra-
tion of datasets can be accomplished to a first approximation.
Here, I illustrate the payoffs of adopting such approaches, with a
worked example of how spatial information within diverse visu-
alizable spaces can be juxtaposed to powerfully inform us about
feeding control substrates and circuits. As we shall see, the field of
ingestive behavior research is potentially poised to act in a man-
ner analogous to Snow in superimposing various datasets upon
one another, with the hopes of gaining new insights about feeding
control circuits in the process.
5.1. EXAMPLE: NPY FEEDING CIRCUITS
Recall from Section 2.3.4.1 that the feeding effects of NPY were
examined systematically in a cannula-mapping study performed
by Stanley et al. (1993b). In that study, they identified the peri-
fornical hypothalamus as a site most sensitive to the orexigenic
effects of centrally nanoinjected NPY. They also identified sev-
eral other regions in the vicinity of the perifornical hypothalamus
that also contained neural substrates sensitive to the peptide.
Importantly, Stanley et al. also tracked the spread of radiola-
beled NPY within tissue and were able to plot its recovery as a
function of distance and time traveled from the injection site ros-
trocaudally. Finally, the locations of their effective injection sites
were plotted within a reference space, the stereotaxic rat brain
atlas of Paxinos and Watson (1986), which in the system of atlas
registration presented in Figure 8, is part of PW1 reference space.
In the context of the topics discussed in Section 4 concerning
visualizable spaces, atlas registration and atlas-based mapping, a
few important facts present themselves concerning the NPY data
just described: (1) the spread of the injected solution was empir-
ically determined through defined distances in tissue; (2) certain
atlas plates in PW1 reference space, containing NPY-sensitive
sites, are partly or fully in register with levels of S reference space;
(3) anterograde tracers such as PHA-L have been deposited at
rostrocaudal levels that are in the vicinity of the NPY injection
sites, thereby delineating neural efferent pathways from those
regions; (4) these traced cells have been mapped in S reference
space; and (5) the feeding-sensitive sites are situated near the
known distributions of key feeding-related cell populations and
receptors.
5.1.1. Aligning empirical, stereotaxic, and reference spaces to
evaluate NPY feeding circuits
Given these facts, the schema in Figure 9 is presented. At the top
of this figure, data obtained from the radiolabeling experiment
(see Figure 3) of Stanley et al. (1993b) are re-plotted to reflect the
hypothesis that the NPY is spreading from injection site “s,” which
corresponds to the locus of NPY’s effects as mapped in Figure 2H
(see right side of Figure 2H; black circles representing intakes; the
site that produced 13 g of food intake in 4 h). The percentages
listed are those established by Stanley et al. (1993b), as the % of
radiolabeled NPY recovered from the tissue (original inset B in
Figure 3). The distance scale corresponding to the original data
is re-plotted as the visualizable space called empirical space, in
mm from the injection site. Given that the effective site is on a
PW reference plate corresponding to a Bregma of−2.80mm, this
has been aligned to the empirical space as stereotaxic space (see
panel A in Figure 9). In panel B, using the atlas conversion chart
in Figure 8, PW atlas plates (labeled as “Reference Space 1”) are
aligned with those S plates (“Reference Space 2”) that are in the
vicinity of the rostrocaudal expanse traveled by the radiolabeled
NPY.
5.1.2. Alignment of additional visualizable spaces
The consequences of placing these levels from two reference spaces
in register is apparent from the data summarized in panels C–F
of Figure 9, which describe the locations of elements in con-
nectomic, proteomic, transcriptomic, and functional visualizable
spaces, respectively.
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FIGURE 9 | An example of how visualizable spaces can be aligned to
help identify neural substrates underlying feeding triggered by an
injection of neuropeptide Y. Data in the radial spread at the top of the figure
are derived from the diffusion data of Stanley et al. (1993b) shown in Figure 3
in this article. The distance traveled by the diffusing solution of injected
radiolabeled neuropeptide Y, is noted along a millimeter axis representing
Empirical Space (A). This space, in turn, is aligned with Stereotaxic Space
(also panel A), and then aligned with (B) Reference Space 1 (Paxinos and
Watson, 1986) and Reference Space 2 (Swanson, 2004). Alignment to these
Reference Spaces allows further registration and alignment with datasets
mapped to these spaces, including (C) Connectomic Spaces; (D) Proteomic
Spaces; (E) Transcriptomic Spaces; and (F) Functional Space. Reference
numbers listed on the right side of the figure refer to the following studies in
this articles reference list: Ref 1: (Paxinos and Watson, 1986); Ref 2:
(Swanson, 2004); Ref 3: Thompson et al. (1996); Ref 4: Hahn and Swanson
(2010); Ref 5: Kopp et al. (2002); Ref 6: Hahn (2010); Ref 7: (Kishi et al., 2005);
Ref 8: (Swanson et al., 2005); Ref 9: (Campbell et al., 2003). See text for a
detailed explanation of this figure.
5.1.2.1. Connectomic space alignment of traced circuits poten-
tially affected by NPY injections. In panel C, Thompson et al.
(1996) used the anterograde tracer, PHA-L, to label cell bodies
within the DMH, which they subsequently mapped to Level 29
of Swanson (case “DMH3” in their study). Similarly, Hahn and
Swanson (2010) mapped PHA-L-labeled cells at Level 29, located
within the lateral hypothalamic area; see cases “LHA11” and
“LHA12” in panel B. The implications of placing these tracer data
in register with the NPY injection site is clear: given the general
anatomical proximity of the LHA and DMH to the injection site
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at Level 29, and the spread of the injected NPY, it is very likely that
NPY solution spread to the areas where the anterogradely traced
neurons are located. If NPY receptors are located on these neu-
rons, then this would suggest further that these traced neurons
could have been activated by the injected NPY. So the next ques-
tion we can ask is: are NPY receptors located in the DMH and
LHA, and if so, have they been mapped to Level 29?
5.1.2.2. Chemoarchitectonic space alignments for NPY recep-
tive neuronal phenotypes. The Y1 subtype of the NPY receptor
(Y1-R) is believed to mediate, in part, the feeding effects of NPY
in rats and mice (Stanley et al., 1992; Lopez-Valpuesta et al.,
1996; Kanatani et al., 2000; see Gehlert, 1999 for a discussion
of the contributions of NPY receptor subtypes in food intake
control). Knowing the distribution of NPY receptors, particu-
larly the Y1-R, in relation to the location of the NPY injection
site is important to begin understanding how NPY’s orexigenic
effects might be mediated. For proteomic spaces (panel D), recall
from Section 4.6.2.1.1 that Kopp et al. (2002) reported the dis-
tribution of immunoreactivity for the Y1-R, and their inferred
coordinates corresponded to Levels 28 and 29 of Swanson (2004)
(e.g., see inferred Bregma coordinates listed at the upper right of
Figure 7B). Thus, it is likely that Y1-Rs are expressed at these atlas
levels.
Within proteomic space, however, it would be of further ben-
efit if the neuronal phenotype (or phenotypes) that expresses
the Y1-R has been identified at these atlas levels. What pheno-
types are present at or near these levels and what is known about
their abilities to respond to NPY via the Y1-R? Campbell et al.
(2003) and Hahn (2010) have noted the existence of hypocre-
tin/orexin (H/O)-expressing neurons in and around this region,
and Hahn (2010) has also reported melanin concentrating hor-
mone (MCH)-immunoreactive neurons at Levels 28 and 29.
Along these same lines, panel E of Figure 9 shows “transcrip-
tomic spaces” corresponding to the known distributions of mRNA
for Y1-Rs (Kishi et al., 2005); H/O (Swanson et al., 2005); and
MCH mRNAs (Swanson et al., 2005), which again corroborate
distributions at these levels.
With respect to proteomic space and Y1-Rs on H/O or MCH
phenotypes, a few other studies merit attention. Campbell et al.
(2003) reported that Y1-R-immunoreactivity is not present on
H/O neurons, but this observation was not specified to a rostro-
caudal level. This absence of location data is noted as “unknown”
(Figure 9, light blue box to the right). Fetissov et al. (2003) also
reported the absence of Y1-Rs on H/O neurons. Y1-R presence
or absence on H/O neurons notwithstanding, it also has been
shown for mouse hypothalamic slices that the predominant elec-
trophysiological action of NPY on H/O neurons is inhibitory
(Fu et al., 2004). Assuming, therefore, that these findings gen-
eralize to rats and are also observed in vivo, any speculation on
NPY triggering feeding through actions at H/O neurons would
have to reconcile this direct inhibitory effect of NPY on H/O
neurons with NPY’s ability to activate a feeding circuit via the
Y1-R following its central nanoinjection into the perifornical
region. Indeed, Fu et al. (2004) also showed that Y1-R ago-
nists reproduced NPY’s inhibitory effect on H/O neurons: even
if H/O neurons had Y1-Rs, they would likely be inhibited by these
receptors. What about MCH neurons at these levels? Y1-Rs are
also reportedly absent on MCH neurons [(Fetissov et al., 2003);
unpublished observations of Campbell et al. (2003), p. 1495], and
again, Fu et al. (2004) reported that NPY directly inhibits MCH
neurons, so any model suggesting MCH neurons could represent
the neuronal phenotypemediating NPY’s orexigenic actions must
also incorporate this as a constraint. Whether putative orexigenic
actions of NPY on H/O or MCH neurons involves inhibition of
an inhibitory circuit (disinhibition) remains to be seen.
Fetissov et al. (2003) also reported the presence of Y1-Rs on
neurons that express nitric oxide synthase (NOS). These neu-
rons were found in the ventromedial hypothalamus, and to a
lesser extent the perifornical hypothalamus, although it again is
unclear at what rostrocaudal level within the hypothalamus these
neurons are found. However, in their Chemoarchitectonic Atlas of
the Rat Brain, Paxinos et al. (2009) provide photomicrographic
documentation for neurons stained for NOS at an inferred stereo-
taxic coordinate of 2.913mmposterior to Bregma (see their Figure
193). These neurons, which were stained for NOS using a nicoti-
namide adenine dinucleotide phosphate diaphorase (NADPH
diaphorase) stain (which marks NOS in a manner that does not
require antibody staining), were located within the ventrome-
dial and perifornical hypothalamus, confirming the findings of
Fetissov et al. Importantly, the inferred stereotaxic space helps to
strengthen the likelihood that the Y1-R-positive NOS neurons
identified by Fetissov et al. (2003) are at or near Levels 28 or 29 of
Swanson reference space.
Functional space has also been mapped in relation to NPY
stimulation, which, according to the report from Campbell et al.
(2003), triggered Fos protein at one level of Reference Space 1
and two additional locations not registerable to any reference
space level (Figure 9F). However, the investigators noted that
intra-hypothalamic injection of NPY in the vicinity of the per-
ifornical region did not trigger Fos expression in H/O or MCH
neurons, consistent with the observations of Fu et al. (2004) that
NPY inhibits these neurons. Finally, notice that the registration
of all of these visualizable spaces allows us to extrapolate on the
basis of Stanley et al. (1993b) that 96% of the radiolabeled NPY
injected into site “s” will spread to rostral and caudal sites up
to 0.4mm away (as illustrated by the yellow box in Figure 9).
Level 29 of Swanson marks the “epicenter” of the manipulation,
and all cellular elements shown in yellow are located at the same
anteroposterior level as the NPY injection site.
5.2. NEUROINFORMATICS TOOLS TO AUTOMATE THE REASONING
PROCESS
The example just worked through (Figure 9) illustrates the power
of utilizing visualizable spaces, atlas registration, and empirical
data concerning central injection of an orexigenic agent (e.g.,
NPY) to create a model where the influence of this neuropep-
tide is constrained across space and time to a few mapped cellular
elements, some of which have established, traced connections to
other regions of the brain. Ideally, then, such an exercise ought
not to be performed by a human experimentalist but by a com-
putational program that interacts with neuroinformatics-based
databases containing records of curated experimental data from
tract-tracing experiments.
The Swanson laboratory has constructed such a system for
use with multiple animal models, especially the rat (Bota et al.,
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2012). Specifically, the Brain Architecture Management System
(or BAMS; http://brancusi.usc.edu/), is a neuroinformatics work-
bench that allows one to query connections that have been
mapped to the Swanson reference space or other reference spaces,
including Paxinos and Watson reference spaces. As of 2013, over
70,000 connection reports exist in the BAMS database (Bota et al.,
2012; Bota and Talpalaru, 2013). The main argument, then, for
creating a system whereby information can be placed in basic reg-
istration with the Swanson reference space is to thereby access
all the mapped connections in S space that are found in BAMS.
Since multiple experimental datasets are present within BAMS,
generated by diverse investigators, the mapping of one’s experi-
mental data to the S reference space allows one to participate in
a community-based project focused on understanding brain cir-
cuits. A prototype co-registration system, called NeuARt II has
been released by the Swanson group as a proof-of-concept that
allows for the superimposition of location data from a variety
of visualizable spaces (connectomic, proteomic, empirical, etc.)
onto horizontal and transverse templates of S reference space
(Burns et al., 2006). Other proofs-of-concept related to these
efforts include electronic laboratory notebook tools and knowl-
edge management systems to help sort and organize the data
obtained for multiple visualizable spaces (Burns et al., 2003; Khan
et al., 2006), and proposed formalizations of modeling language
to manage connectivity data (Brown and Swanson, 2013). Finally,
the second and third editions of the Swanson atlas (Swanson,
1999, 2004) include digital templates of each atlas plate in Adobe
Illustrator format (discussed in Swanson, 2001). One can read-
ily superimpose datasets onto these atlas plates by using the layer
manager palette in Illustrator to overlay a transparent layer onto
the atlas map and place location data in register with other data
drawn onto different layers.
6. CONCLUDING REMARKS
Pioneering creatures, when venturing or peering into uncharted
places, usually return helpful information about the locations of
such places to their companions. Subsequent journeys or obser-
vations then refine the initial maps that are formed of these places,
in a form of culture- and community-based quorum sensing
(Huth, 2013). Evidence for this is well documented for hon-
eybees (von Frisch, 1953; Seeley and Visscher, 2004; Visscher,
2007; Seeley et al., 2012), cosmologists (Ferris, 1983; Rowan-
Robinson, 1985), Antarctic explorers (Shackleton, 1919; Byrd,
1938; Sullivan, 1957; Pulsifer and Taylor, 2005; Pulsifer et al.,
2005, 2007), and neuroscientists (Table 4; see also Figure 2 in
Swanson, 2000b). Members of the last group, venturing out for
their first time, are just as likely as the first three groups, if not
more, to become lost if the valuable spatial information provided
by their pioneers is ignored, forgotten, or misunderstood.
7. NOTE ADDED IN PROOF
The Stuber laboratory has recently reported that optogenetic
stimulation of GABAergic neurons in the bed nucleus of the
stria terminalis suppresses the activity of lateral hypothalamic
glutamatergic neurons to stimulate food intake (Jennings et al.,
2013). In their published Supplementary Material, optical fiber
placements are plotted in gross anatomic and stereotaxic space.
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